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On molecular level, cells sense changes in oxygen availability through the prolyl-4-hydroxylase domain 
enzymes (PHDs), which in turn regulate the protein stability of the α-subunit of the transcription factor 
hypoxia-inducible factor (HIF). By using molecular oxygen PHDs 1 - 3 hydroxylate two specific proline 
residues thereby marking HIFα for proteasomal degradation. Among the three PHD isoforms the 
constitutively expressed PHD2 is the main regulator of HIFα stability and thus hypoxia-inducible gene 
expression in normoxia. PHD3 is highly induced under hypoxic conditions and serves as a negative 
feedback regulator. Especially PHD3 has been additionally associated with apoptotic cell death. I 
hypothesized that PHD3 plays a role in cell-fate decisions in macrophages. Therefore, myeloid-specific 
PHD3 knockout mice (PHD3
-/-
) were created and analyzed. PHD3-deficient bone marrow-derived 
macrophages (BMDM) showed no altered HIF-1α or HIF-2α stabilization or increased HIF target gene 
expression in normoxia or hypoxia. Macrophage M1 and M2-polarization was unchanged likewise. 
Compared to macrophages from wild type littermates PHD3
-/-
 exhibited a significant reduction in TUNEL 
positive cells after serum withdrawal. Under the same conditions the PHD3
-/-
 macrophages also showed 
less Annexin V staining which detects the membrane disruption indicating a reduced early apoptosis. 
Application of apoptotic inducers such as S-nitroso-N-acetyl penicillamine (SNAP) or staurosporine also 
showed PHD3
-/-
 cells to be less apoptotic. Additionally, calcein uptake results indicate that PHD3
-/-
 
macrophages are more viable. When the supernatant (medium) from the cultured macrophages was 
exchanged between the genotypes after 24 hrs of culture, then PHD3
-/-
 macrophages showed more 
Annexin V staining suggesting that at least in part a secreted factor is involved in the PHD3 induced 
apoptosis mechanism. In an unbiased transcriptome screen the expression of a secretory glycoprotein 
angiopoietin-like protein 2 (Angptl2) expressions was found to be reduced in PHD3
-/-
 BMDM under stress 
conditions. Addition of recombinant Angptl2 rescued the anti-apoptotic phenotype demonstrating that it is 
involved in the PHD3-mediated response towards apoptotic stimuli in macrophages. Additionally Angptl2
-/-
 
BMDM showed decreased apoptosis compared to wild type which support the lower expression of Angptl2 
in PHD3
-/-
 BMDM followed by decreased apoptosis. My data suggests that the anti-apoptotic effects in the 
PHD3
-/- 








Molecular oxygen (O2) is essential for life; it plays an important role in human physiology. Subsequently, 
oxygen is indispensable for the molecular metabolism and adequate oxygen supply is the prerequisite for 
the appropriate functionality of each cell, tissue and organ (Carreau et al., 2011). Oxygen is available at 
the molecular level to tissues and cells by diffusion. The oxygenation in different tissues varies between 
30 – 50 mmHg which is comparable to 4 – 7% of the atmospheric pressure at sea level (Almendros et al., 
2010; Qiao et al., 2007). Insufficient oxygen availability to tissues and cells is termed as hypoxia which 
can be caused by both physiological and pathophysiological reasons. A physiological condition that may 
lead to an increase of oxygen consumption and thus leads to hypoxia even at  sea level, is for example 
heavy exercise (Garvey et al., 2012). In contrast to this, a pathophysiological condition, e.g. differentiation 
of stem cells inside the stromal niche during infection leads to inadequate supply of oxygen causing 
hypoxia which needs cellular adaptation to overcome the hypoxic effects (Carreau et al., 2011; 
Dunwoodie, 2009; Lee et al., 2001). Also a ventilation/perfusion mismatch resulting from progressive 
airflow limitation and emphysema can cause hypoxia leading to chronic obstructive pulmonary disease 
(Kent et al., 2011).  Pathological hypoxia can be caused by local ischemia due to the loss of blood supply 
or in massive tumors because of impaired vascularization (Acker and Plate, 2003).  Since oxygen is 
essential for the functioning of each and every tissue and organ the cell has regulatory mechanisms to 
adapt to the changes in oxygen availability. The key regulators of this response are the hypoxia-inducible 
transcription factors (HIFs) which activate oxygen-dependent gene expression (Fong, 2009).  
1.2 Hypoxia-inducible factors 
 
Hypoxia-inducible factors (HIFs) are transcription factors which accumulate under low oxygen 
concentrations and regulate the expression of hypoxia-inducible genes. HIFs are the principal mediators 
of homeostasis of cells and tissues experiencing hypoxia (Semenza, 2004). They regulate more than 





and apoptosis (Semenza, 2012). HIFs are heterodimeric transcription factors consisting of an α-subunit 
and a HIF-1β-subunit, which is also known as aryl hydrocarbon receptor nuclear translocator (ARNT). 
Three major HIFα family members are known: HIF-1α, HIF-2α and HIF-3α. Both subunits, α and β are 
composed of basic helix-loop-helix proteins (bHLH) of the Per-Arnt-Sim (PAS) family. HIF-1β forms a 
complex together with HIF-1α, HIF-2α and HIF-3α (Wang et al., 1995; Makino et al., 2002), these dimers 
bind to a DNA motif in the hypoxia response elements (HREs) that leads to the transcriptional activation 
(Wang et al., 1995; Wenger, 2002). HIF-1β mRNA and protein levels are unaltered with changes in 
oxygen availability. In contrast, in the presence of oxygen the HIFα subunits undergo the process of 
hydroxylation, polyubiquitination and proteasomal degradation, resulting in a half life of HIFα of about 5 
min (Salceda and Caro, 1997). Low oxygen concentration leads to an insufficient hydroxylation and 
thereby to a HIFα subunit stabilization (Huang et al., 1998; Salceda and Caro, 1997; Roy et al., 2004). 
HIF-1 drives the initial response to hypoxia whereas HIF-2 plays an important role in chronic hypoxic 
exposure (Koh et al., 2011). HIF-3 acts as a negative regulator of HIF-1 and HIF-2 (Makino et al., 2002; 
Yamashita et al., 2008). 
1.2.1 HIF-1α 
 
The human HIF-1α protein is constitutively and ubiquitously expressed and has a molecular weight of 
around 120 kDa (Wang and Semenza, 1993). It is a member of the basic helix-loop-helix (bHLH) PAS 
protein family. HIF-1α contains two transactivation domains; the N-terminal (N-TAD) and the C-terminal 
(C-TAD) and also contains an oxygen-dependent degradation domain (ODD) that regulates oxygen 
dependent stability (Pugh et al., 1997). The C-TAD interacts with co-activators like CBP/p300 to activate 
transcription. When N803 present in the C-TAD is hydroxylated it blocks the recruitment of transcriptional 
coactivator CBP/p300 (Ruas et al., 2002; Lando et al., 2002).  The ODD domain contains two conserved 
proline residues, P402 and P564 that are hydroxylated by prolyl-4-hydroxylase domain enzymes (PHDs) 
and one lysine residue, K532 which is acetylated by acetyltransferase named arrest-defective-1 in an 
oxygen-dependent manner (Ke and Costa, 2006; Koh et al., 2011) (Fig. 1). The stability and activity of 
HIF-1α are regulated by post-translational modifications such as hydroxylation, acetylation and 





residues (P402 and P564), one asparagine residue (N803) and acetylation of a lysine residue (K532) 
triggers HIF-1α for poly-ubiquitination leading to degradation by the proteasome pathway (Ke and Costa, 
2006; Koh et al., 2011; Mahon et al., 2001). HIF-1α is stabilized and active during short periods (2 – 24 
hrs) of intense hypoxia or anoxia, subsequently negative feedback regulators lead to a decrease in the 
protein level.  
 
Figure 1: Domain structure of human HIF-1α 
The protein contains two transactivation domains (C-TAD and N-TAD).  HIF-1α contains an ODD that mediates oxygen-regulated 
stability through the hydroxylation of two proline (P402 and P562) residues, an asparagines residue (N803) and the acetylation of a 
lysine (K 532). 
1.2.2 HIF-2α 
 
HIF-2α has 48% of amino acid sequence and structure similarity to HIF-1α, but they have different target 
genes and mechanism of regulation. It is predominantly expressed in lung, epithelium and carotid body 
(Ema et al., 1997). HIF-2α also contains transactivation domains at N-terminal (N-TAD) and C-terminal (C-
TAD) in the C-terminal half (Koh and Powis, 2012). The open reading frame of HIF-2α encodes 870 aa 
with a molecular weight of the protein of 118 kDa (Fig. 2). HIF-2α is hydroxylated at much lower efficiency 
than HIF-1α (Koivunen et al., 2004) and therefore senses the chronic hypoxia exposure (Koh et al., 2011). 
In human HIF-2α is hydroxylated at the two conserved proline residues P405 and P531 (Koh et al., 2011) 
and the asparagine residue N 851 in the C-TAD domain is hydroxylated (Mahon et al., 2001)(Fig. 2).   
 
Figure 2: Domain structure of human HIF-2α 
The protein contains two transactivation domains (C-TAD and N-TAD) and an oxygen-dependent degradation domain (ODD) 








HIF-3α is not as widely studied as HIF-1α and HIF-2α, the role of HIF-3α under hypoxia and its mode of 
action is far more unclear. The HIF-3α open reading frame encodes 626 aa resulting in a protein with a 
molecular weight of 73 kDa which is predominately expressed in adult thymus, lung, brain, heart, and 
kidney. It is the shortest HIFα-isoform composed of the bHLH and PAS domains but lacking the carboxy-
terminal domain (Gu et al., 1998), having only one TAD motif. It has a unique leucine zipper domain 
(LZIP) (Gu et al., 1998) (Fig. 3). Multiple splice variants of HIF-3α exist. The most studied variant is the 
inhibitory PAS domain protein (IPAS) (Makino et al., 2002). Under normoxia HIF-3α is degraded by 
hydroxylation in an oxygen dependent manner (Zhang et al., 2014) but in hypoxia it can inhibit the action 
of HIF-1α and HIF-2α by acting as a competitor against HIF-1α or HIF-2α by binding to Arnt or forming a 
dimer with HIF-1α itself (Makino et al., 2002; Yamashita et al., 2008; Hara et al., 2001).  
 
Figure 3: Domain structure of human HIF-3α 
HIF-3α contains besides the basic helix loop helix (bHLH) and Per-Arnt-Sim (PAS) domains only one transactivation domain (N-





HIF-1β, also known as aryl hydrocarbon receptor nuclear translocator (Arnt), belongs to the bHLH protein 
family containing a PAS domain but it lacks the amino terminal N-TAD domain (Fig.4). HIF-1β consists of 
789 aa with a molecular weight of 86 kDa and is constitutively expressed irrespectively of oxygen 
availability and is stable under normoxic conditions. HIF-1β forms heterodimers with many bHLH-PAS 
family proteins such as aryl hydrocarbon receptor (AhR) and HIF-1α, HIF-2α and HIF-3α. (Wang et al., 






Figure 4: Domain structure of human HIF-1β 
HIF-1β contains besides the basic helix loop helix (bHLH) and Per-Arnt-Sim (PAS) domains one C-terminal transactivation domain 
(C-TAD). 
 
1.3 Regulation of HIFα 
 
The protein stability of HIFα is regulated by the prolyl-4-hydroxylase domain enzymes (PHDs) by 
hydroxylation at specific proline residues, followed by ubiquitination and proteasomal degradation 
(Jaakkola et al., 2001). Additionally, HIF-1α and HIF-2α are also regulated by asparaginyl hydroxylation 
leading to transcriptional inactivation by factor inhibiting HIF (FIH) (Lando et al., 2002). Both hydroxylase 
domain enzymes, PHDs and FIH, require oxygen, 2-oxoglutarate, ascorbate and iron (Fe
2+
) as co-factors 
(Jaakkola et al., 2001; Lando et al., 2002) (Fig. 5).  
 
 
Figure 5: Hydroxylation of HIF-1α 
Under the consumption of oxygen, hypoxia-inducible factor (HIF)-1α is hydroxylated at specific prolyl residues/asparagine residues 
by prolyl hydroxylase domain enzymes (PHDs)/factor inhibiting HIF (FIH) in the presence of Fe
2+ 
2-oxoglutarate (2-OG) and 
ascorbate. 
 
HIFα is hydroxylated by PHDs at two specific proline residues situated in the ODD domain which 
promotes interaction/binding of HIFα with the von Hippel-Lindau protein (pVHL) to the ODD domain of 





which facilitates the polyubiqutination of HIFα thereby marking it for degradation by the 26S proteasome 
(Kallio et al., 1999; Ohh et al., 2000).  Under hypoxic conditions, because of the unavailability of oxygen 
as co-factor, the PHDs are inhibited from hydroxylating HIFα, which in turn inhibits the binding of pVHL 
hence leading to the stabilization of HIFα. Accumulated HIFα is then translocated into the nucleus where it 
heterodimerizes with HIF-1β. The complex is able to activate the expression of hypoxia target genes by 
binding to cis-acting HRE located in the enhancer or promoter regions (Epstein et al., 2001; Jaakkola et 
al., 2001; Pugh and Ratcliffe, 2003). Hence, stabilization of HIFα affects various pathways in the cell for 
example angiogenesis, cell proliferation, metabolism, and apoptosis (Fig. 6). A high number of genes 
related to angiogenesis are upregulated under hypoxia. Vascular endothelial cell growth factor (VEGF) is 
one among them which recruits endothelial cells to the site of hypoxia and induces proliferation. The 
induction of VEGF in hypoxia is a sign of pro-angiogenesis and vessel formation (Josko et al., 2000). Also 
genes such as matrix metalloproteinases (MMPs) involved in matrix metabolism and vessel maturation 
are induced in hypoxia. Cells adapt to hypoxia by switching the metabolism from oxygen-dependent 
tricarboxylic acid cycle (TCA) cycle to oxygen independent glycolysis. To meet the required ATP synthesis 
the cells increase glucose uptake. Therefore, under hypoxia cells induce the expression of glycolytic 
enzymes such as pyruvate kinase M (PKM), Phosphofructokinase (Pfk), Hexokinase, and glucose 
transporters such as Glut 1 and Glut 3, which are indeed HIF target genes (Wenger, 2002; Mora et al., 
2005; Chen et al., 2003). HIF also induces the expression of growth factors such as adrenomedullin, 
insulin like growth factor 2 and transforming growth factor-α. Hifα stabilization also leads to the induction 
of apoptosis related genes such as BNip3, Bcl-2 and caspase-3 (Flamant et al., 2010; Webster et al., 








Figure 6: HIF-1α regulation by PHDs   
In normoxia, hypoxia inducible factor (HIF)-1α is hydroxylated by prolyl hydroxylase domain enzymes (PHDs) in the presence of O2, 
Fe
2+
, 2-oxoglutarate (2-OG) and ascorbate. Hydroxylated HIF-1α is recognised by the von Hippel-Lindau (pVHL) protein, which 
marks HIF-1α with polyubiquitin, this leads to the recognition for proteasomal degradation. Under hypoxia, proline hydroxylation is 
inhibited, VHL is no longer able to bind and target HIF-1α for proteasomal degradation, which leads to HIF-1α accumulation and 
translocation to the nucleus. HIF-1α dimerises with HIF-1β, binds to hypoxia-response elements (HREs) within the promoters or 
enhancers of target genes and induces transcriptional activity. A range of cell functions are regulated by the target genes, such as 
cell proliferation, apoptosis, survival and erythropoiesis. 
 
The second major mechanism controlling HIFα regulation is done by another oxygen regulated enzyme, 
FIH. FIH hydroxylates HIF at asparagines within the C-TAD domain. This hydroxylation inhibits the 
interaction with the transcription co-activators p300/CREB- and hence inhibits transcriptional activation of 
all target genes. Like PHDs, FIH also requires oxygen, 2-oxoglutarate, ascorbate and iron (Fe
2+
) as co-






1.4 Prolyl-4-hydroxylase Domain Enzyme (PHD) 
 
 PHDs are enzymes that use di-oxygen to hydroxylate their substrates and simultaneously convert 2-
oxoglutarate (2-OG) into succinate and release CO2 as byproduct (McDonough et al., 2006; Elkins et al., 
2003). During hydroxylation, PHDs use the oxygen molecule, dissolve the covalent bond and split it into 
two, one oxygen atom hydroxylates the proline residue and the other reacts with 2-OG to generate 
succinate and CO2 (Bruick and McKnight, 2001; Masson and Ratcliffe, 2003). All the co-factors are 
essential for the hydroxylation activity of PHDs. For example, inhibition of the PHDs by 2-OG analogs can 
increase the half life of HIFα (Jaakkola et al., 2001). Fe
2+
 at the active site of the PHDs is bound to two 
histidine residues and one aspartic acid forming a 2-histidine-1-carboxylate coordination motif. Ascorbate 
helps to maintain iron in the ferrous (Fe
2+
) state which is important to achieve the full enzyme activity 
(Epstein et al., 2001; Bruick and McKnight, 2001). The apparent KM value for all the PHD enzymes is in 
between 230-250 µM which exceeds even the concentration of oxygen in air at sea level making these 
enzymes suitable oxygen sensors (Hirsila et al., 2003). In Drosophila melanogaster and Caenorhabditis 
elegans similar to PHDs a single family member is present which is known as Fatiga and egg laying 
defective nine (EGLN) respectively (Epstein et al., 2001; Centanin et al., 2005). In mammals, there are 
four members that belong to the PHD protein family, PHD1 also known as EGLN2, PHD2 also known as 
EGLN1, PHD3 also known as EGLN3 and the recently discovered P4HTM (prolyl 4-hydroxylase, 
transmembrane). In addition to being oxygen sensors, PHDs are also known to be involved in the 
hydroxylation of non-HIF substrates and also in hydroxylase independent functions (for examples please 
see table 1.2) (Cummins et al., 2006; Takeda and Fong, 2007; Ozer et al., 2005).  
All PHDs can hydroxylate HIFα in-vitro; however there are differences in the hydroxylation potential, PHD2 
has the highest potential followed by PHD3, and PHD1. PHD2 is the most important enzyme for 
hydroxylating HIFα in normoxia. (Huang et al., 2002). Under hypoxia, mRNA and protein expression of 
PHD2 is mildly induced, expression of PHD3 is strongly induced under hypoxia whereas expression of 
PHD1 remains unaffected (Epstein et al., 2001; Metzen et al., 2003). PHD2 is mostly localized in the 
cytoplasm, PHD1 is localized in the nucleus and PHD3 is localized both in cytoplasm and nucleus. PHD2 





al., 2003). All enzymes are expressed widely in many tissues but they exhibit tissue specific 
overexpression. PHD1 is abundant in the testis, PHD2 in skeletal muscles and adipose tissue, PHD3 in 
the heart and placenta (Lieb et al., 2002). 
The structure of PHDs consists of two domains: the variable N-terminal domain (≈21–58 aa) has 
homology to MYND zinc finger domains and the conserved catalytic C-terminal domain (≈181–426 aa) 
has homology to other 2-OG dioxygenases. The catalytic core domain of PHDs consists of eight β-
strands/double stranded β-helices supported by three conserved α-helices and other β-strands and loops 
that pack along the core (McDonough et al., 2006)(Fig. 7). 
 
Adapted from (McDonough et al., 2006) 
Figure 7: Crystal structure of PHD2 
PHD2 consists of a C-terminal domain and a N-terminal domain formed by eight β-strands in a “jelly-role”or double stranded β helix 














PHD1 also named as EGLN2, is constitutively expressed but predominantly expressed in testis and 
localized in the nucleus. Full length human PHD1 consists of 407 aa and has a molecular weight of 
around 43 kDa. Resulting from two alternative translational initiations, PHD1 has two isoforms with 
molecular weights of 40 and 43 kDa. (Epstein et al., 2001; Lieb et al., 2002). PHD1 has been shown to be 
involved in the mitochondrial energy metabolism (Aragones et al., 2008). Loss of PHD1 decreases 
oxidative stress in liver cell metabolism resulting in increased hypoxic survival (Schneider et al., 2010) and 
increases the intestinal barrier function and thus is protective against colitis (Tambuwala et al., 2010).  
1.4.2 PHD2  
 
PHD2 also known as EGLN1, consists of 426 aa and has a molecular weight of 46 kDa and is highly 
expressed in skeletal muscles and adipose tissue. PHD2 is the most important enzyme to hydroxylate 
HIFα in normoxia (Huang et al., 2002). Therefore human hereditary mutations of PHD2 results in a 
decreased enzyme activity and are associated with familial erythrocytosis, one such mutation is P317R 
(Percy et al., 2006). The complete knockout of PHD2 is lethal (Takeda et al., 2006). PHD2 has a higher 
specificity towards HIF-1α compared to HIF-2α and is transcriptionally regulated by HIF. Therefore it is 
mildly induced under hypoxia. PHD2 is known to play a major physiological role during placental and 
cardiac development (Takeda et al., 2006). In mice haplodeficiency of PHD2 can normalize the 
vasculature of expanding tumors, leading to improved tumor oxygenation and delay in metastasis 
(Mazzone et al., 2009). 
1.4.3 PHD3 
 
Human PHD3 also known as EGLN3 is a 239 aa long protein with a molecular weight of 27 kDa and is 
mostly expressed in the heart and placenta. PHD3 protein is transcriptionally upregulated by HIF 
(Pescador et al., 2005) and is strongly hypoxia inducible (Appelhoff et al., 2004). The specific role of 
PHD3 upregulation under hypoxia is not clear. However, studies suggest that the hypoxic induction of 





already been demonstrated that acute induction of hypoxia leads to a transient rise in HIF-1α protein 
levels, following a brief time period these levels subsequently return back to baseline despite continued 
hypoxia. This might have resulted from the hypoxia-induced PHD3 expression, which enables cells to 
effectively increase HIF-1α hydroxylation even under hypoxia.  
PHD3 has been reported to be involved in the development of the sympatho-adrenal system (Bishop et 
al., 2008) and induces apoptosis in cultured rat sympathetic neurons by withdrawal of nerve growth factor 
(Lipscomb et al., 1999). Also it has been shown to induce apoptotic cell death in neurons and 
pheochromocytoma cell line (PC12) cells (Lipscomb et al., 2001; Lee et al., 2005). In relation to myeloid 
cells, PHD3 has been shown to regulate the life span of neutrophils under hypoxia (Walmsley et al., 
2011). In macrophages, loss of PHD3 enhances the innate immune response by accumulating pro-
inflammatory macrophage function (Kiss et al., 2012). Other than myeloid cells, PHD3 negatively 
regulates the NFκB pathway (Fu and Taubman, 2013; Xue et al., 2010). Upregulation of PHD3 is 
associated with p53 induced growth arrest and apoptosis in Rat sarcoma (RAS)-transformed embryo 
fibroblasts (Madden et al., 1996). PHD3 stimulates pyruvate kinase M2 co-activation of HIF-1 (Luo et al., 
2011) and it regulates Bcl-2 mediated apoptosis in H9c2 cells (Liu et al., 2010). PHD3 targets and 
interacting proteins are listed below in the table 1.1. 
 Table 1.1 adapted from (Place and Domann, 2013) 
Targets Function  Interaction Reference 
HIFα Degradation Hydroxylation (Elkins et al., 2003; 
Appelhoff et al., 
2004) 
ATF-4 Regulator of transcription 
factor 
Binding (Wottawa et al., 
2010; Koditz et al., 
2007)  
PKM2 HIF-1 activation Hydroxylation (Luo, Hu et al. 2011) 






Bcl-2 Reduce formation of Bax-
Bcl-2 complex 
Binding  (Liu et al., 2010) 
hCLK2 DNA damage Hydroxylation (Xie et al., 2012) 
IKKβ Negative regulator of 
NFκB 
Binding  (Xue et al., 2010) 
Kinesin like 
protein1Bβ 
Induction of apoptosis Hydroxylation (Schlisio et al., 2008) 
 
1.4.3.1 Known role of PHD3 in pro-survival effect 
 
PHD3 has been shown in many studies to have a pro-survival role by affecting apoptotic pathways under 
hypoxic conditions in several cell types. For example, PHD3 has also been known to play a role in cell 
viability under hypoxic conditions in tumor samples where its upregulation correlates with increased 
aggressiveness in cancers (Chen et al., 2011b), also in head and neck carcinoma cells PHD3 appears to 
promote cell cycle progression from G1-S phase (Hogel et al., 2011). PHD3 has been shown to increase 
the life span of neutrophils under hypoxia (Walmsley et al., 2011). One mechanism, known for this 
increased survival is the effect of PHD3 on cell metabolism. Both PHD3 and PKM2 have been shown to 
complex with nuclear HIF-1α, inducing transcription of genes involved in glycolysis (Luo et al., 2011). This 
leads to a higher production of ATP through the glycolytic pathway during hypoxia. A similar study showed 
an interaction between PKM2 and PHD3 in the cytosol, where it regulates flux of carbon through glycolysis 
(Chen et al., 2011a). Thus, under hypoxia PHD3 may promote cell survival by modulating metabolic 
genes.  
1.4.3.2 Known role of PHD3 in pro-apoptotic effect 
 
In spite of several studies pointing towards the role of PHD3 in cell survival, evidence for the role of PHD3 
in inducing apoptosis is pre-dominant in the literature. It has been shown in neurons during 
sympathoadrenal development that loss of PHD3 resulted in a decrease of apoptotic cells (Bishop et al., 





of PHD3 (Lee et al., 2005; Lipscomb et al., 1999). Another similar study shows that, nerve growth factor 
withdrawal from a rat pheochromocytoma cell line resulted in c-jun mediated PHD3 upregulation inducing 
cell death (Straub et al., 2003). Kinesin KIF1Bβ has been shown to act downstream of PHD3 to mediate 
pro-apoptotic effects (Schlisio et al., 2008). Apart from neurons, also in muscle cells PHD3 has been 
shown to interact with Bcl-2, inhibiting the formation of the Bax-Bcl-2 complex which finally results in cell 
apoptosis (Liu et al., 2010). Further, PHD3 hydroxylates human Biological Clock Protein (hCLK2) and 
promotes apoptosis through activation of the p53 mediated DNA damage response pathway (Xie et al., 
2012). In a cervical cancer cell line it has been shown that PHD3 localizes into large punctuated 
cytoplasmic aggregates followed by apoptosis (Rantanen et al., 2008). 
1.5 PHDs targets other than HIFs 
 
PHDs can regulate other downstream targets than HIFs although it is not clear if it involves direct 
hydroxylation by the involved PHDs or not.  For example PHD1 and PHD3 inhibit the IkB kinase (IKK) in 
the NFκB pathway (Xue et al., 2010). Another role of PHD3 is the hydroxylation of pyruvate kinase isoform 
PKM2 which enhances the PKM2 binding to HIF-1α (Luo et al., 2011). PHD2 may directly interact with 
Phosphodiesterase 4D to function as a regulator of the intracellular cAMP levels in cardiomyocytes (Huo 
et al., 2012). A recent study showed that PHD3 regulates the ion channel TRPA1 by hydroxylation 
(Takahashi et al., 2011).  Table1.1 below summarizes all the targets and binding partners of the different 
PHDs known so far. 
Table1.2 adapted from (Wong et al., 2013) 
Target  Abbreviation  PHD Isoform Interaction Reference 
Inhibitor of kappaB 
kinase β 
IKKβ PHD1/2/3 Hydroxylation (Fu and Taubman, 
2010; Cummins et 
al., 2006) 
Pyruvate kinase muscle 
factor2 
PKM2 PHD2 Binding (Luo et al., 2011) 






potential cation channel, 
member A1 
TRPA1 PHD1/3 Hydroxylation (Takahashi et al., 
2011) 
FK506 binding protein 38 FKBP38 PHD2 Binding (Barth et al., 2009) 
Seven in absentia 
homolog 2 




ATF4 PHD1/3 Binding (Koditz et al., 
2007; Hiwatashi et 
al., 2011) 
Human precursor RNA 
processing 19 
hPRP19 PHD3 Binding (Sato et al., 2010) 
Paired box gene 2 Pax2 PHD3 Hydroxylation (Yan et al., 2011) 
Sprouty homolog 2 Spry2 PHD1/2/3 Hydroxylation (Anderson et al., 
2011)Anderson, 
Nordquist et al., 
2011) 
TCP-1 ring complex TRiC PHD3 Binding (Masson et al., 
2004) 
Mitogen-activated 
protein kinase organizer 
1  
Morg1 PHD3 Binding (Hopfer et al., 
2006) 
Inhibitor of growth 
protein 4 
ING4 PHD2 Binding (Ozer et al., 2005) 
Iron-only hydrogenase-
like protein1 
IOP1 PHD2 Binding (Huang et al., 
2007) 
Cerebellar degeneration 
related protein 2 









Kinesin-like protein1B β KIF1Bβ PHD3 Hydroxylation (Schlisio et al., 
2008) 
Large subunit of RNA 
polymerase II 
Rbp1 PHD1/2 Hydroxylation (Mikhaylova et al., 
2008) 
 
1.6 Hypoxia and myeloid cells 
 
Myeloid cells are comprised of cells having common descendants from progenitors derived from 
hematopoietic stem cells in the bone marrow. Granulocytes and monocytes together are called myeloid 
cells. These are short living immune cells that respond and move to any change in tissue integrity or 
microbial invasion. They move to the affected tissue and phagocytose the microorganisms and damaged 
tissue debris or release antimicrobial molecules and pro-inflammatory factors. The role of macrophages 
and neutrophils in the regulation of microbial infection and inflammation is the central mechanism of innate 
immunity. In particular neutrophil apoptosis is important for the onset of granulocytic inflammation. HIF-1 is 
known to prolong the neutrophil viability by inhibiting apoptosis under hypoxia (Walmsley et al., 2005) and 
in von Hippel-Lindau disease having mutation in one VHL allele, neutrophils showed reduced apoptosis 
and induced phagocytosis of bacteria (Walmsley et al., 2008). In myeloid cells, HIF-1α knockout shows 
less efficient phagocytosis in eliminating bacteria during infection (Peyssonnaux et al., 2005). HIF-
dependent functions of myeloid cells in oxygen depleted areas are well known (Cramer et al., 2003).  
1.7.1 Hypoxia and macrophages 
 
Macrophages are highly elastic immune cells which are derived from bone marrow progenitors, which 
proliferate continuously and release monocytes into the blood stream. Monocytes circulate in the blood 
stream for 1-2 days before migrating into the tissues to differentiate into macrophages, which exhibit 
various tissue specific functions and protect the body from infection by bacteria, viruses and other 
pathogens. Therefore, macrophages are found in all kind of tissues of the body. Huge extravasation of 
monocytes into the tissue is a sign of early onset of inflammation. Wound healing and various diseases in 





antimicrobial activity, antigen presenting and tissue invasion (Fig. 1.8) (Ross and Rosen, 2002). Tissue 
hypoxia can be caused by various ways such as inflammation, wound healing or due to occlusion of the 
local blood supply. It has been shown in the literature that macrophages accumulate in large numbers in 
such hypoxic tissues and respond to the hypoxia by altered gene expression mediated by activation of 
both HIF-1 and HIF-2 target genes (Semenza, 2004; Burke et al., 2003; Talks et al., 2000). Numerous 
studies showed the changes in gene expression in macrophages in the hypoxic sites, for example altered 
VEGF, Glut-1, IL-1, TNF-α, IL-6, MMPs have been shown in the literature in macrophages under hypoxia 
(Lewis et al., 2000).  
Wounds have areas of hypoxia due to lack of perfusion caused by vascular damage. Initially neutrophils 
infiltrate the wound, increase their number and stay at the hypoxic site for 1-2 days post wound formation. 
This is followed by monocyte recruitment which peaks at days 2 till 5. Both macrophages and neutrophils 
phagocyte debris and secrete factors which attract additional immune cells to the site of the wound that 
facilitate neovascularization (Allen et al., 1997).  In an animal model of myocardial infarction, hypoxic 
areas are detected, where significantly higher numbers of macrophage accumulation has been shown 
(Azzawi et al., 2005). Studies showed that HIF-1α and HIF-2α are upregulated in these macrophages 






Figure adapted and modified from (Eltzschig and Carmeliet, 2011) 
Figure 8: Myeloid cell response to hypoxia/ inflammation 
The schematic explains the invasion of immune cells to the hypoxic or inflamed site. Inflamed hypoxic tissue mount a host defense 
response which amplifies the recruitment of innate immune cells such as neutrophils, mast cells or macrophages to the site of 
infection.  
 
1.8 Angiopoietin-like protein 2 (Angptl2) 
 
Angiopoietins belong to the family of proteins which regulate angiogenesis and hematopoietic stem cell 
differentiation (Yancopoulos et al., 2000; Suda et al., 2005) . It has been reported that tyrosine kinase with 
immunoglobulin-like and EGF-like domains 1 (Tie2) is the receptor for the members of the angiopoietin 





was identified and is designated as angiopoietin-like proteins (Angptls).  Angptls contain an N-terminal 
coiled-coil domain and a C-terminal fibrinogen-like domain (Hato et al., 2008). They do not bind to the 
receptor Tie2, suggesting that Angptls have a different signaling mechanism than that of angiopoietins 
(Hato et al., 2008). It has recently been reported that LILRB2 and PIRB are receptors for several Angptl 
family members (Zheng et al., 2012; Oike et al., 2004). The family of Angptls consists of seven members, 
Angptl1-7. 
Angptl2 is constitutively expressed in several cell types including monocytes and macrophages and in 
tumor cells (Okada et al., 2010; Aoi et al., 2011; Tazume et al., 2012). It has been reported that Angptl2 
plays a crucial role in mediating obesity, tumor metastasis, rheumatoid arthritis and in inducing 
atherosclerotic diseases through chronic inflammation (Tabata et al., 2009; Tazume et al., 2012; Endo et 
al., 2012; Aoi et al., 2011; Okada et al., 2010). 
1.9 Angptl2 and inflammation 
 
Literature reports several studies about the role of Angptl2 in both chronic and acute inflammation. For 
example, Angptl2 has been reported to mediate persistent low grade inflammation by activating NFκB 
signaling through α5β1 integrin receptor (Tabata et al., 2009). Another similar study suggests that Angptl2 
derived from infiltrating macrophages accelerates abdominal aortic aneurysm progression by inducing 
chronic inflammation and degradation in the aneurismal vessel wall (Tazume et al., 2012).  Studies also 
show correlation between chronic inflammation and Angptl2 expression level which induces tumor 
metastasis (Aoi et al., 2011).  This study was done by inducing skin squamous cell carcinoma (SCC) in a 
mouse model and expression of Angptl2 in this mouse model correlates with the frequency of 
carcinogenesis which is found to be caused by the accumulation of ROS due to chronic inflammation. 
Higher ROS level can inhibit the DNA repair enzyme machinery leading to increased risk of 
carcinogenesis (Aoi et al., 2011). Also during acute inflammation, Angptl2 has been shown to be induced 
by endotoxin in the eye (Kanda et al., 2012). Angptl2 is also induced during fin regeneration in adult 





Interestingly, reports also showed a stress related induction in the expression and secretion of Angptl2. In 
adipocytes, ER stress increases Angptl2 expression and secretion (Tabata et al., 2009). Most 
interestingly, Angptl2 mRNA levels in tumor cells are significantly increased under hypoxia and starvation 






















1.10 Aim of the study 
 
The stability of the transcription factor HIFα is regulated by PHD enzymes in an oxygen dependent 
manner. Under normoxia PHD1-3 enzymes utilize molecular oxygen to hydroxylate HIFα and mark it for 
proteasomal degradation. Contrary, under hypoxic conditions HIFα is stabilized and can modulate 
hypoxia-dependent cell functions. Hypoxia is a common feature of infected and inflamed tissues, tumors, 
wounds, and atherosclerotic lesions. Myeloid cells are attracted to these hypoxic areas and a strong 
accumulation of macrophages can be observed. They are able to adapt rapidly to hypoxia by altered gene 
and protein expression profiles by activating hypoxia inducible factor signaling pathways and this 
influences the outcome of the diseases. The involvement of HIF in modulating inflammation has been well 
described in the literature.  As macrophage function and hypoxia are important players in health and 
disease I aimed to investigate how macrophages are influenced by targeting HIF-signaling. PHDs are 
known to be expressed in myeloid cells and interfering with any of these PHD isoforms might alter the 
response of the immune system. As the PHD isoforms differ in enzyme activity, the isoform specific 
function of PHDs in myeloid cells needs to be investigated separately. A huge number of recent studies 
support the role of PHD3 in cell differentiation, survival, apoptosis, and metabolism. In myeloid cells loss 
of PHD3 is known to enhance the innate immune response (Kiss et al., 2012) and regulate the life span of 
neutrophils under hypoxia (Walmsley et al., 2011). However the specific role of PHD3 in macrophages is 
less explained so far. Therefore, the aim of this thesis was to investigate the role of PHD3 in macrophage 
specific function in a newly generated myeloid specific PHD3 knockout mouse line. To investigate the 
broad role following sub goals were set. 
a) Isolation, differentiation and characterization of PHD3
-/- 
BMDMs - I first aimed to isolate and 
differentiate BMDM and do general characterization of these in-vitro 8 days differentiated 
macrophages. These characterizations include confirming the knockdown by protein expression 
and gene expression analysis, doing morphological analysis and examining the macrophage 
differentiation efficiency. 
b) To examine the polarization of macrophages - Macrophages can differentiate into two 





was to investigate if the PHD3
-/- 
BMDM differentiate into a distinct subpopulation both with and 
without stimulations by gene expression analysis and cytokine protein expression analysis. 
 
c)   To identity the effect of PHD3
-/- 
on BMDM viability - For PHD3 a connection to apoptotic cell death 
mechanisms has been reported in various cell type. Therefore I was interested to investigate the 
effect of PHD3
-/- 
in BMDMs using assays such as TUNEL assay, Annexin V assay, and calcein 
uptake assay. 
 
d)   Molecular studies of PHD3
-/-
 BMDM - To further identify the molecular mechanisms of PHD3 on 
macrophage function I performed a transcriptome screen and analyzed the identified candidate 


























Table 2.1: List of used chemicals and materials 
Name of the chemical Provider 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazoliumbromid (MTT) 




Wako Pure chemicals, Osaka, Japan 
Accutase PAA Laboratories, Cölbe, Germany 
Bovine serum albumin 
 
Applichem, Darmstadt, Germany 
Complete Mini EDTA-free Protease Inhibitor Roche Applied Science, Mannheim, Germany 
Dimethyl sulfoxide (DMSO)  Carl Roth GmbH, Karlsruhe, Germany 
Dimethyloxaloylglycine (DMOG)  
 
Frontier Scientific, Carnforth, UK  
EDTA PAN
™ 
biotech GmbH, Passau, Germany 




biotech GmbH, Passau, Germany  
GeneRuler™ 1kb Plus DNA Ladder  Fermentas GmbH, St. Leon-Rot, Germany 
 
Glycine  Carl Roth GmbH, Karlsruhe, Germany 
HEPES PAN
™ 





biotech GmbH, Passau, Germany 
Interferon  (IFN) Peprotech, Hamburg, Germany 
Interleukin (IL)-4 Peprotech, Hamburg, Germany 
KCl Carl Roth GmbH, Karlsruhe, Germany 
L-glutamine PAN
™ 
biotech GmbH, Passau, Germany 




Lipopolysaccharide (LPS) Enzo Life Sciences, Lörrach, Germany 
Methanol Carl Roth GmbH, Karlsruhe, Germany 
NaCl Carl Roth GmbH, Karlsruhe, Germany 
NaOH Carl Roth GmbH, Karlsruhe, Germany 
PageRuler™ Prestained Protein Ladder  Fermentas GmbH, St. Leon-Rot, Germany  
 
Penicillin/streptomycin for cell culture  PAN
™ 
biotech GmbH, Passau, Germany  
 
Phalloidin Invitrogen, Germany 
S-nitroso-N-acetylpenicillamine (SNAP) Santa Cruz 
Sodium Citrate Carl Roth GmbH, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Carl Roth GmbH, Karlsruhe, Germany 
Sodium Pyruvate PAN
™ 
biotech GmbH, Passau, Germany 
Staurosporine Enzo Life Sciences, Lörrach, Germany 




Carl Roth GmbH, Karlsruhe, Germany 
Triton X Carl Roth GmbH, Karlsruhe, Germany 
Triton X-100 Carl Roth GmbH, Karlsruhe, Germany 
Trizol Invitrogen, Darmstadt, Germany 
Trypan blue Sigma, United Kingdom 
β-mercaptoethanol Carl Roth GmbH, Karlsruhe, Germany 
Annexin V Biolegend,London, United Kingdom 












Table 2.2 List of buffers used 
Buffer Composition 
Western blot transfer buffer  25 mM Tris 
192 mM glycine 
800 ml H2O 
10% SDS 
200 ml methanol  
DEPC-treated water  2 ml diethylpyrocarbonate 
1 l H2O  
Enhanced luminol-based chemiluminescent 
substrate (ECL) 
100 mM Tris/HCl, pH 8.5 
90 mM coumaric acid  
250 mM luminol  
0.009% H2O2  
Lysis Buffer  
 
400 mM NaCl 
10 mM Tris/HCl, pH 8 
1 mM EDTA, pH 8 
0.1% TritonX100 
H2O 
Phosphate buffered saline (PBS)  137  mM NaCl 
2.7 mM KCl 
4.3 mM Na2HPO4·7H2O 
1.4 mM KH2PO4, pH 7.4 
5x SDS electrophoresis buffer  125 mM Tris 
1.25 M glycine 
0.5% SDS, pH 8.3  
2x SDS-sample buffer 100 mM Tris/HCl, pH 6.8 
4% SDS 
0.2% bromphenol blue 
20% glycerol 
5% β-mercaptoethanol  
10x TAE  
 
0.4 M Tris acetate 
10 mM EDTA, pH 8.3 
0.1x TE  
 
1 mM Tris 
0.1 mM EDTA, pH 8.0  
6x DNA sample buffer  
 
30% glycerine 
0.25% bromphenol blue 
0.25% Xylene cyanole FF  
 H2O  
Tris/HCl 40 mM Tris, pH 5.0 
Alkaline tail lysis buffer 25 mM NaOH 











Table 2.3 List of antibodies used for western blots 
Antibody 
against 
Source Provider Dilution Catlog number 
β-actin 
 
mouse Sigma  1:10000  A 5441  
HIF-1α  mouse Novus Biologicals 1:1000 NB-100-479 
HIF-2α  goat R&D Systems 1:500 AF2997 
PHD2 mouse Novus Biologicals 1:1000 NB 100-2219 
PHD3 rabbit Novus Biologicals 1:500 NB100-303 
Secondary 
antibodies 
    
rabbit HRP goat SantaCruz 1:1000 Sc-2004 
mouse HRP goat SantaCruz 1:1000 Sc-2005 
 
Table 2.4 List of antibodies used for FACS 
Antibodies  Provider 
anti-Alpha5 integrin Biolegend, London, United Kingdom 
anti-integrin β1 Biolegend, London, United Kingdom 
anti-CD11b BD Bioscience, Heidelberg, Germany 
anti-Pir-A/B Biolegend, London, United Kingdom 
anti-F4/80 Biolegend, London, United Kingdom 
Rat IgG2a Biolegend, London, United Kingdom 
IgG Biolegend, London, United Kingdom 
Rat IgGК1 Biolegend, London, United Kingdom 
 
 




2.1.4 Cell culture medium 
 
Table 2.5 List of cell culture medium 
Medium Composition/Provider 
Culture medium DMEM 
10% FCS 
1% sodium pyruvate  





 biotech GmbH, Passau, Germany 
Pluznik DMEM 
10% FCS  
5% Horse serum 
30% L929 conditioned medium 







Table 2.6 List of primers used for qRT-PCR 
mRNA Primer name Primer  sequence Annealing 
temperature 
PHD3 mPHD3 for 5’-GGCCGCTGTATCACCTGTAT-3’ 60°C 
 mPHD3 rev 5’-TTCTGCCCTTTCTTCAGCAT-3’  
MS12 mS12 for 5’-GAAGCTGCCAAGGCCTTAGA-3’ 58°C 
 mS12 rev 5’-AACTGCAACCAACCACCTTC-3’  
TNFα mTNFa for 5’-GACCCTCACACTCAGATCATCTTC-3’ 58°C 
 mTNFa rev 5’-CCACTTGGTGGTTTGCTACGA-3’  
iNos miNOS for 5’-AAGTCCAGCCGCACCACCCT-3’ 58°C 
 miNOS rev 5’-TCCGTGGCAAAGCGAGCCAG-3’  




Arginase mArginase for 5’-AGGACAGCCTCGAGGAGGGG-3’   58°C 
 mArginase rev 5’-CCCTGGCGTGGCCAGAGATG-3’    
Fizz mFizz for 5’-TCCCAGTGAATACTGATGAGA-3’ 54°C 
 mFizz rev 5’-CCACTCTGGATCTCCCAAGA-3’  
PHD1 mPHD1 for 5’-GCTAGGCTGAGGGAGGAAGT-3’ 60°C 
 mPHD1 rev 5’-TCTACCCAGGCAATCTGGTC-3’  
PHD2 PHD2_ex3/5 for 5’-TTGCTGACATTGAACCCAAA-3’ 58°C 
 PHD2_ex5 rev 5’-GGCAACTGAGAGGCTGTAGG-3’  
PKM2 mPKM2 for 5’-AACCGAAGTACGCCCGAGGAC-3’ 58°C 
 mPKM2 rev 5’-ATCGGGAAGCAGGCCCAATGGT-3’  
Pfk mPfkl  for 5’-ACGAGGCCATCCAGCTCCGT-3’ 59°C 
 mPfkl rev 5’-TGGGGCTTGGGCAGTGTCCT-3’  
Pdk1 mpdk1 for 5’-GTTCACGTCACGCTGGGCGA-3’ 66°C 
 mpdk1 rev 5’-CCAGGCGTCCCATGTGCGTT-3’  
Ym-1 mYm1 for 5’-GCCAGCAGAAGCTCTCCAGAAGCAA-3’ 59°C 
 mYm1 rev 5’-ACTGAACGGGGCAGGTCCAAACT-3’  
IL-6 mIL6 for 5’-GCTGGTGACAACCACGGCCT-3’   58°C 
 mIL6  rev 5’-TGCACAACTCTTTTCTCATTTCCACGA -3’   
Angptl2 mAngptl2 for 5’-ACCTCAACAGGTACAAGCGG-3’ 60°C 
 mAngptl2 rev 5’-CTCACGATGCCTCCGTCTAC-3’  
CD36 mCD36 for 5’-GCATCACCCCTCCAGAATCC-3’ 60°C 
 mCD36 rev 5’-TGGTCCCAGTCTCATTTAGCC-3’  
Primers for 
genotype PCR 
   




PHD3 PHD3 for 5’-CCACGTTAACTCTAGAGCCACTGA-3’ 58°C 
 PHD3 rev 5’-ATGGCCGCTGTATCACCTGTAT-3’  
LysM-cre LysMcre for 5’-GTTCGCAAGAACCTGATGGACA-3’ 60°C 
 LysMcre rev 5’-GTTCGCAAGAACCTGATGGACA-3’  
 
2.1.6 Commercial kits  
 
Table 2.6 List of kits used 
Application Name of the kit Provider 
Angptl2 ELISA ELISA kit for the detection of 
Angptl2 
Uscn Life sciences Inc, Wuhan, 
China 
cDNA synthesis  First Strand cDNA synthesis kit Fermentas GmbH, St. Leon-Rot, 
Germany 
Cytokine detection BD catometric Bead array mouse 
inflammation kit instruction 
BD biosciences, Germany 
PCR  PCR Master Mix K0171 Thermoscientific 
real-time PCR  Brilliant II SYBR Green qPCR  Bioline, Luckenwalde, Germany 
Transcriptome assay One-Color Microarray-Based 
Gene Expression analysis kit 
Agilent technologies 
TUNEL Assay In-situ cell death detection kit, 
fluorescein 
Roche Diagnostics, Mannheim 
Germany 










2.1.7 Software  
 
Table 2.7 List of software used 
Program Application Source 
CorelDraw  Image editor  Corel Corporation 
Image J Image analysis Imagej.nih.gov 
Axio-vision Image analysis Carl Zeiss 
Blast  Sequence alignment  Ncbi.nlm.nih.gov 
Graphpad Prism Statistical analysis GraphPad Software Inc. 
Multi Gauge   Western blot analysis  Fujifilm Corporation  
EndNote  Managing of bibliographic 
references  
Thomson, Wintertree Software 
Inc.  
BD FCAP Array software 3.0 FACS analysis BD Biosciences 




Table 2.8 List of instruments used 
Application Name of the instrument Manufacturer 
Centrifugation  Centrifuge 5415R  
 
 
Centrifuge 5810R  
 
 
Micro Centrifuge  
Eppendorf AG Hamburg, 
Germany 
Eppendorf AG Hamburg, 
Germany  
Carl Roth GmbH and Co. KG, 
Karlsruhe, Germany  
Cleanbench  HERA safe KS 12  
 
Thermo Electron Corporation, 
Langenselbold, Germany  
Flow cytometer BD FACS Canto II flowcytometer BD Biosciences 
Fluorescence microscope Axio Observer D1 Zeiss, Germany 
Gel Doc Gene flash UV imager Syngene bio imaging, UK 




Heating Block Block thermo stat BT2000 Kleinfeld Labortechnik, Germany 
Incubation shaker  Minitron  INFORNS HT AG, Bottmingen, 
Switzerland  
Incubator for cell culture CB159  Binder GmbH, Tuttlingen, 
Germany  
Luminometer  Centro LB 960  Berthold Technologies GmbH & 
Co. KG, Bad Wildbad Germany  
Magnetic stirrer Ikamag® RH IKA Labortech, Staufen, 
Germany 
Micro plate reader  Model 680  Bio-Rad, München, Germany  
Microscope Motic® AE30 TED, Pella Inc, USA 
Oxygen-controlled work 
station 
In Vivo2 400  Ruskin Technologies, Bridgend, 
UK  
PCR cycler  Primus 96 Thermocycler  Peqlab, Erlangen, Germany  
Photometer  Smart SpecTM Plus  Bio-Rad, München, Germany  
Power supply   
Real-time PCR cycler  
 
Mx3000P  Stratagene, La Jolla, USA  
Rotator  Rotator RS-24  G.Kisker GbR, Steinfurt, 
Germany  
UV-transilluminator  InGenius  Syngene, Camebridge, UK  
Vortex Vortex gemie 2 Scientific industries, Germany 
Water bath  Water bath Medigen, Germany 
Western blot  PerfectBlueSemi-Dry 
elektroblotter  
Fujifilm, Düsseldorf, Germany  
Western blot imaging  LAS 3000 Imager  Fujifilm, Düsseldorf, Germany  
Western blot transfer  PerfectBlue Double gel system 
Twin  









2.2.1 Myeloid-specific conditional PHD3 knockout (PHD3-/-) mice 
 
The generation and detailed characterization of Phd3 
flox/flox
 mice were reported previously (Takeda et al., 
2006). The mice were kindly provided by Prof. Guo-Hua Fong, Center for Vascular Biology, University of 
Conneticut Health Center, Farmington, USA. All animals in this study were backcrossed to C57BL/6 mice 
at least five times. Phd3 
flox/flox









 mice were then crossed with 
Phd3 
flox/flox










).   
2.2.2 Isolation of gDNA 
 
Small pieces of ear/tail clipping from mice were taken in 75 µl of alkaline tail lysis buffer. Then the samples 
were incubated for 1 hour at 95°C for tissue lysis and subsequently transferred to 4°C for 10 min. 75 µl of 
40 mM Tris/HCl buffer was added. Out of this, 5 µl of sample were taken for performing PCR.  
 
2.2.3 Polymerase chain reaction 
 
For the amplification of DNA, the well described polymerase chain reaction (PCR) method was used. 
Genomic DNA from mouse tail was used as template. PCR was performed in a total reaction volume of 25 
μl containing 6.5 μl ddH2O, 12.5 µl PCR master mix, 5 μl DNA template, 0.5 μl forward primer (10 
pmol/μl), and 0.5 μl reverse primer (10 pmol/μl). The reaction was carried out in the Primus 96 









Table 2.9 Parameters used for PCR cycling 
 Step Temperature Duration Number of cycles 

















Final extension    72°C 10 min 1 
 
2.2.4 Differentiation and cultivation of bone marrow-derived 
macrophages 
 
Bone marrow-derived macrophages (BMDM) are primary macrophages, derived from bone marrow cells 
in vitro in the presence of colony stimulating and growth factors. Macrophage colony-stimulating factor (M-
CSF) is a lineage-specific growth factor that is responsible for the proliferation and differentiation of 
committed myeloid progenitors into cells of the macrophage/monocyte lineage.  
In this protocol, bone marrow cells were grown in petridishes in the presence of M-CSF, which is secreted 
by L929 cells and is used in the form of L929-conditioned medium. The efficiency of the differentiation was 
assessed using fluorescence-activated cell sorting (FACS) analysis of F4/80 surface antigen expression 
(Weischenfeldt and Porse, 2008). The differentiated BMDMs are suitable for various experiments, for 
example morphological, gene expression, and physiological analysis.  
For the isolation of bone marrow cells mice were sacrificed by cervical dislocation at the age of 8-12 
weeks. Bone marrow cells were isolated from the femur by flushing 10 ml of culture medium through the 
bone. The flushed cells were then cultured on cell culture dishes in culture at 37°C and 5% CO2 in a 
humidified incubator as described before (Burgess et al., 1985). After 24 hrs non-adherent monocytes 
were harvested, seeded in pluznik medium and differentiated for 3-8 days. Adherent BMDM were 
detached with 3.5 ml accutase and resuspended in culture medium. 
 
 




2.2.5 Isolation of RNA 
 
For RNA isolation 0.7 x 10
6
 BMDM were seeded in 2 ml culture medium in 6-well plates and incubated for 
4, 24 and 48 hrs at 37°C and 5% CO2 in normoxia (20% O2) or hypoxia (1% O2) using the In Vivo 400 
work station. Cells were washed once with PBS and harvested in 1 ml of Trizol per well. The samples 
were then collected in a 1.5 ml eppendorf tube and were incubated for 5 min at room temperature. 200 μl 
of chloroform was added and mixed well by inverting the tubes for 6 times followed by incubation for 3 
min. Samples were centrifuged at 12000xg at 4°C for 15 min. Then the aqueous upper layer was 
transferred into a new eppendorf tube. 500 µl isopropanol was added to each sample and vortexed, 
incubated for 10 min at room temperature, then again incubated for 10 min at -20°C and centrifuged at 
12000g at 4°C for 10 min. The supernatant was discarded, the pellet was washed using 1 ml 75% ethanol. 
After centrifuging at 7000g 4°C for 10 min, the supernatant was carefully discarded and the pellet was 
dried. After drying it was dissolved in 15 µl of RNase free water. The RNA solution was incubated at 56°C 
for 10 min. Then the samples were stored at -80°C. 
2.2.6 RNA concentration measurement 
 
After RNA isolation, the concentrations of the samples were determined by measuring the absorption at 
260 nm and 280 nm using the BioAnalyzer. The threshold for a sufficient purity of RNA samples was 
determined by the 260 nm/280 nm ratio of 1.8, presence of proteins in the samples decreases the ratio. 
2.2.7 cDNA synthesis 
 
The ability to synthesize DNA from an RNA template, using reverse transcriptase is explored for the 
process of cDNA synthesis. 1 µg of RNA was used for the synthesis of cDNA using the First strand cDNA 
synthesis kit. For the synthesis of cDNA a mixture of 11 µl consisting of 1 µg RNA, H2O and 1 µl Oligo-dT 
was prepared and incubated for 65° C for 5 min then the samples were immediately transferred onto ice 
for 5 min. To each of the tubes a 9 µl mastermix composed of 2 µl dNTP, 1 µl Ribolock, 2 µl reverse 
transcriptase, and 4 µl RT buffer was added. The samples were incubated at 37° C for one hour. The 
reaction was stopped by inactivating the reverse transcriptase by incubating at 70° C for 5 min. 




2.2.8 Quantitative real-time PCR 
 
A quantitative real-time polymerase chain reaction (qRT-PCR) is a PCR technique, which is used to 
amplify and simultaneously quantify a DNA template. In quantitative PCR, the amount of the amplified 
product is linked to fluorescence intensity using a fluorescent reporter molecule, a DNA-intercalating dye 
that glows once it binds to double-stranded DNA. An increase in DNA product during PCR therefore leads 
to an increase in fluorescence intensity and is measured at each cycle, thus allowing DNA concentrations 
to be quantified. However, dsDNA dyes such as SYBR Green will bind to all dsDNA PCR products, 
including nonspecific PCR products (such as Primer dimer). This can potentially interfere with, or prevent, 
accurate quantification of the intended target sequence. As a reference dye ROX
TM
 was added to the 
samples to normalize the fluorescence signal intensity between the reactions. With reference to a 
standard dilution, the dsDNA concentration in the PCR can be determined. The quantification can be 
either is done by an absolute number of copies or a relative amount when normalized to DNA input or 
additional normalizing genes using any housekeeping gene. This quantitation approach is termed the 
comparative Ct method. Ct (threshold cycle) is a relative measure of the concentration of target in the PCR 
reaction. This method of analysis involves comparing the Ct values of the samples of interest with a 
control or calibrator such as a non-treated sample or RNA from normal tissue. The Ct values of both the 
calibrator and the samples of interest are normalized to an appropriate endogenous housekeeping gene. 
 
Transcript levels were analyzed by qRT-PCR with the Brilliant II SYBR Green qPCR Master Mix in an 
MX3005Pro light cycler. For the reaction 1 μl cDNA, 12.5 μl SYBR Advantage qPCR Premix (2x), 0.5 μl 
forward primer (10 μM), 0.5 μl reverse primer (10 μM) and 0.5 μl ROX reference dye LMP were mixed and 









Table 2.10 Parameters used for qRT-PCR cycling 
 Step Temperature Duration Cycles 
Denaturation   Denaturation   95°C 30 sec 1 
 
PCR 
  Denaturation   95°C 10 sec  
40   Annealing   T °C 20 sec 


















2.2.9 Protein extraction  
 
For protein extraction 4x10
6 
cells were seeded in 10 ml culture medium in tissue culture grade petridishes 
and incubated for 24 hrs at 37°C and 5% CO2 in normoxia (20% O2) or hypoxia (1% O2). For harvesting, 
the cells were washed once with PBS and 175 µl of lysis buffer were added to each 10 cm dish. An EDTA-
free protease-inhibitor was added to the lysis buffer to prevent protein degradation. The cells were 
scraped from the dishes and the cell lysate was transferred into a 1.5 ml eppendorf tube. The samples 
were placed on ice for about 10 min. The lysed cells were pelleted by centrifugation at 12000 rpm for 20 
min at 4°C and the supernatant was transferred into a new 1.5 ml eppendorf tube. The protein 
concentration was measured by performing a Bradford protein concentration assay. 
2.2.10 Bradford Protein concentration assay 
 
The Bradford protein concentration assay, a colorimetric protein assay, is based on an absorbance shift of 
the dye Coomassie Brilliant Blue G-250. During this assay under acidic conditions the red form of the dye 
is converted into its bluer form upon binding to the protein. Under acidic conditions, the dye is 




predominantly in the doubly protonated red cationic form which has an maximum absorbance at 470 nm. 
When the dye binds to proteins, it is converted to a stable unprotonated blue form which has an 
absorbance at 595 nm (Compton and Jones 1985). The linear range of Bradford assay is from 0 µg/ml to 
2000 µg/ml.  A standard curve was prepared from a series of standards between 0.5 μg and 5 μg bovine 
serum albumin (BSA). For the Bradford assay, 1 μl of the sample was added to 200 μl of 1:5 times diluted 
Protein Assay Reagent from Bio-Rad and the absorbance was measured at 595 nm. The concentration of 
the unknown protein samples was determined using the standard curve. 
2.2.11 SDS-Polyacrylamide gel electrophoresis (PAGE) 
 
Polyacrylamide gel electrophoresis (PAGE) is a technique to separate biological macromolecules for 
example proteins or nucleic acids according to their molecular weight. To eliminate the effect of folding 
structures, proteins are treated with sodium dodecyl sulphate (SDS), an anionic detergent, to denaturate 
the protein by breaking the secondary and non–disulfide–linked tertiary structures. SDS additionally 
applies a negative charge to each protein in proportion to its mass. The negative charge of the proteins by 
SDS makes the proteins run towards the positive electrode during electrophoresis. The reducing agent β-
mercaptoethanol further denatures the proteins by reducing disulfide linkages and breaking up quaternary 
protein structures. The sample buffer contains a tracking dye which has a higher electrophoretic mobility 
than the analytes to allow the experimenter to track the progress of the solution through the gel during the 
electrophoretic run. The preparation of a gel needs two different layers of acrylamide. The lower layer 
resolving gel is responsible for actually separating polypeptides by size. The upper layer stacking gel has 
the sample wells, it sweeps up the sample that they are compressed into micrometer thin layers when 
they reach the separating gel to have a uniform start before the separation. The pH conditions in the 
stacking gel result in the samples to stack between the fast migrating chloride ions and the slower 
migrating glycine from the sample buffer at the starting point above the resolving gel. Usually 10-12% of 
acrylamide is used for the preparation of the gel. 
Double the volume of SDS sample buffer was added to 80-100 µg of protein. Before loading the samples 
to the 12% SDS polyacrylamide gel, the samples were boiled at 95°C for 10 min. The prestained 






marker was loaded along with the samples onto the gel. The electrophoresis was run at a 
constant current of 40-45 mA with maximum voltage set at 300 V. 
Table 2.11 Composition of stacking and resolving gel 
 Stacking gel Resolving gel 10% Resolving gel 12% 
H2O 6.8 ml 11.9 ml 9.9 ml 
30% acrylamide mix 1.7 ml 10 ml 12 ml 
1 M Tris pH6.8 1.25 ml - - 
1.5 M Tris pH8.8 - 7.5 ml 7.5 ml 
10%  ammonium 
persulfate 
1 ml 0.3 ml 0.3 ml 
10% SDS 1 ml 0.3 ml 0.3 ml 
TEMED 0.01 ml 0.012 ml 0.12 ml 
 
2.2.12 Western blot Development 
 
The separated proteins on the gel were transferred onto a nitrocellulose membrane. For transfer of 
proteins, the gel and the nitrocellulose membrane were equilibrated in western blot transfer buffer. The gel 
and the nitrocellulose membrane were then sandwiched between filter papers already soaked in blotting 
buffer. The transfer was performed using PerfectBlue Semi-Dry Electroblotter with a constant current 
setting of 2 mA/cm
2
 for 1 hour. The membrane was analyzed for the protein expression of interest by 
using primary antibody against it. The primary antibodies were then detected by horseradish peroxidase 
conjugated secondary antibodies which are raised against the Fc region of the primary antibody. 
After transfer the membrane was washed with PBS for 10 min. Then the confirmation of the quality of 
transfer was controlled by Ponceau S staining. The membrane was washed three times with PBS to get 
rid of the Ponceau S staining. The blot was blocked with 5% milk in PBS for 1 hour at room temperature to 
prevent unspecific binding of the antibodies. Dilution of the primary antibody was prepared in PBS 




containing 5% non fat milk and was applied on to the blot and incubated overnight at 4°C. The used 
dilutions of the antibodies are listed in Tab. 2.3. 
After overnight incubation of the primary antibody at 4°C, the membrane was washed thrice for 10 min 
with PBS. The secondary antibody which is conjugated to horseradish peroxidase is diluted in PBS 
containing 5% non fat milk. The membrane was incubated in secondary antibody for 2 hrs at room 
temperature. The membrane was washed three times with PBS for 10 min each. 10 ml of ECL solution 
was applied on to the membrane for development. The blot was developed by exposing the membrane 
onto X-ray films or was imaged using the LAS3000 Imager from Fujifilm for different exposure times. 
2.2.13 TUNEL ASSAY 
 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay detects DNA 
fragmentations by labeling the terminal end of nucleic acids. The hallmark of apoptosis is DNA 
degradation, which in early stages, is selective to the internucleosomal DNA linker regions. The DNA 
cleavage may yield double-stranded and single-stranded DNA breaks (nicks). Both types of breaks can be 
detected by labeling the free 3'-OH terminal with modified nucleotides (e.g., biotin-dUTP, DIG-dUTP, 
fluorescein-dUTP) in an enzymatic reaction. The enzyme terminal deoxynucleotidyl transferase (TdT) 
catalyzes the template-independent polymerization of deoxyribonucleotides to the 3'-end of single- and 
double-stranded DNA.  
0.5 x 10
6
 BMDM were seeded in 6-well plates on coverslips in 2 ml culture medium and were incubated 
for 48 hrs at 37°C and 5% CO2 in normoxia (20% O2) or hypoxia (1% O2). The cells were then washed 
with PBS and fixed using 4% PFA for 20 min. The cells were permeabilized using 0.1% TritonX-100 in 
freshly prepared 0.1% sodium citrate for 2 min on ice and were then stained for 60 min at 37ºC in a dark 
and moist chamber using enzyme and labelling solution provided by the fluorescein in-situ cell death 
detection kit. Cells treated with DNAse served as positive control. The cells were then washed with PBS 
and were imaged using the Axio Observer fluorescence microscope. 
 




2.2.14 Annexin V Staining 
 
Phospholipids of the cell membrane are asymmetrically distributed between the inner and outer leaflets of 
the membrane. Phosphatidylcholine and sphingomyelin are exposed on the external leaflet of the lipid 
bilayer, while phosphatidylserine is located on the inner surface. During apoptosis, this asymmetry is 
disrupted and phosphatidylserine becomes exposed on the outside surface of the plasma membrane. 
Because the anticoagulant protein Annexin V binds with high affinity to phosphatidylserine, the 
fluorochrome-conjugated Annexin V can been used to detect apoptotic cells by flow cytometry. 
BMDM were seeded in 35 mm dishes in culture medium with and without serum. After 48 hrs the cells 
were detached using accutase for 15 min and cells were counted. 1.5 x 10
6
 cells per sample were 
subsequently analyzed. After washing with PBS cells were stained with Annexin V and propidium iodide 
for 20 min at 4 ºC. Then the cells were resuspended in Annexin V binding buffer and were anlysed using 
the BD FACS Canto flow cytometer. In some experiments, cells were treated with 100 µM S-Nitroso-N-
Acetyl-D,L-Penicillamine (SNAP) or 500 nM staurosporine or 5-10 µg/ml LPS for 12 hrs.  
2.2.15 Flow cytometry 
 
Flow cytometry is a laser-based method for cell counting, cell sorting, biomarker detection and protein 
engineering, by suspending cells in a stream of fluid and passing them by an electronic detection 
apparatus. It allows simultaneous multiparametric analysis of the physical and chemical characteristics of 
up to thousands of particles per second. Fluorescence-activated cell sorting (FACS) is a specialized type 
of flow cytometry. It provides a method for sorting a heterogeneous mixture of biological cells into two or 
more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics 
of each cell. FACS provides fast, objective and quantitative recording of fluorescent signals from individual 
cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used 
as labels in flow cytometry.  
0.5x10
6 
cells were cultured in 35 mm petridishes for 24 and 48 hrs at 37°C and 5% CO2 in normoxia (20% 
O2) or hypoxia (1% O2). 0.2x10
6
 cells were taken in a FACS tube for further analysis. Then the cells were 
washed with PBS and were incubated with anti-Pir-A/B, anti-F4/80, anti-integrin α5, anti-integrin β1, anti-




CD11b and the respective control antibodies rat IgGk1, rat IgG2a, IgG for 20 min at 4°C. After washing 
with PBS cells were resuspended in 100 µl of binding buffer and analyzed using the flow cytometer. 
2.2.16 Calcein-AM cell viability assay 
 
Calcein-AM is a non-fluorescent, hydrophobic compound that easily permeates intact, living cells. The 
hydrolysis of Calcein-AM by intracellular esterase produces calcein, a hydrophilic, strongly fluorescent 
compound that is well-retained in the cell cytoplasm. Cells, preferably grown in black-walled plates, can be 
stained and quantified in less than two hrs. 0.2x10
5 
cells were grown in 200 µl of culture medium in black 
walled 96 well plates for 4, 12, 24 and 48 hrs at 37°C at 20% O2 or 1% O2. The cell viability was 
determined using the Calcein-AM cell viability assay kit. Before measurement, the plate was taken out 
from 37°C and was centrifuged at 250 g for 5 min. Supernatant was discarded and 100 µl of 1X calcein 
AM DW buffer was added to each well. Then again the plate was centrifuged at 250g for 5 min. The 
calcein AM DW buffer was removed and 50 µl of fresh calcein AM DW buffer was added. To each well, 50 
µl of freshly diluted 2X AM working solution was added. The plate was then incubated for 30 min at 37°C. 
The fluorescence was measured using a 490 nm excitation filter and a 520 nm emission filter. The 
fluorescence intensity is proportional to the number of viable cells. 
2.2.17 Angptl2 ELISA 
 
The enzyme-linked immunosorbent assay (ELISA) is a method which uses antibodies to identify a specific 
substance. Antigens from the sample are attached to a surface coated with a specific antibody. A second 
antibody is linked to an enzyme, and, in the final step, a substance containing the enzyme's substrate is 
added. The subsequent reaction produces a detectable signal, most commonly a color change in the 
substrate. The microtiter plate had been pre-coated with an antibody specific to Angptl2. Standards and 
samples were then added to the appropriate microtiter plate wells with a biotin-conjugated antibody 
specific to Angptl2. Then Avidin conjugated to horseradish peroxidase (HRP) was added to each micro 
plate well. After 3,3',5,5'-Tetramethylbenzidine(TMB) substrate solution is added, only those wells that 
contain Angptl2, biotin-conjugated antibody and enzyme-conjugated Avidin exhibited a change in color. 
The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color 




change is measured spectrophotometrically at a wavelength of 450 nm ± 10 nm. The concentration of 
Angptl2 in the samples is then determined by comparing the O.D. of the samples to the standard curve. 
0.75x10
6
 cells were grown in 200 µl of culture medium in black walled 6 well plates for 4, 12, 24,and 48 
hrs at 37°C at 20% O2 or 1% O2. The supernatant was harvested for the ELISA. 100 µl of prepared 
standards or samples were added to a 96 well coated plate. The wells were then incubated for 2 hrs at 
37°C.The supernatant was then discarded and 100 µl of detection reagent A was added. The wells were 
then incubated for 1 hour at 37°C. The supernatant was again discarded and the wells were washed three 
times with washing buffer. Then 100 µl of detection reagent B was added. The wells were then incubated 
for 30 min at 37°C. The supernatant was discarded and the wells were washed five times with washing 
buffer. 90 µl of substrate solution were added and incubated for 15-25 min at 37°C.  50 µl of stop solution 
were added and the absorbance of the samples was measured at 450 nm using a micro plate reader. 
2.2.18 Transcriptome screen 
 
A microarray chip consists of DNA spots on a solid chip. It is used to measure the expression of a large 
number of genes simultaneously. Each spot on a microarray contains multiple identical strands of DNA. 
The DNA sequence on each spot is unique and represents one gene. Thousands of spots are arrayed in 
orderly rows and columns on a solid surface. The precise location and sequence of each spot is recorded 
in a computer database. Microarrays can be the size of a microscope slide, or even smaller. Probe-target 
hybridization is usually detected and quantified by detection of fluorophore-, or chemiluminescence-
labeled targets to determine relative abundance of nucleic acid sequences in the target. 
0.7 x 10
6
 BMDM were seeded in 2 ml culture medium in 6-well plates and incubated for 48 hrs at 37°C 
and 5% CO2 in 20% O2 or 1% O2. Cells were washed once with PBS and harvested in Trizol. RNA was 
isolated (section 2.2.5) and 1 µg RNA was transcribed using the First Strand cDNA Synthesis Kit (section 
2.2.7). RNA integrity was determined (section 2.2.6). RNA was then added to the Spike mix provided with 
the Agilent Technologies, One-Color Microarray-Based Gene Expression analysis kit. Samples were then 
labeled according to the Agilent – Low Input Quick Amp Labeling, one color protocol. cDNA was 
synthesized from the labeled mRNA. Amplified RNA (aRNA) was then synthesized using T7 RNA 
polymerase enzyme. Quantification of the labeled aRNA was done before hybridization onto the 




microarray slides. The hybridization was then carried out on the Agilent Microarray Hybridization slide at 
65ºC for 17 hrs. All subsequent steps were followed as instructed by Low Input Quick Amp Labeling 
protocol. The whole transcriptome screen and analysis of the raw data was performed in collaboration with 
the Transkriptions Analyse Labor (TAL, University Medical Center Göttingen). 
2.2.19 Statistics 
 
All the statistical evaluations were performed using graph pad prism 4 software. Statistical analyses were 
performed using Student`s two-tailed t-test. Data are shown as means ± SD. Values of p<0.05 were 
















3.1 Generation of myeloid-specific PHD3 knockout mice 
The results of the study are in part published (Swain et al., 2014). Figures of the publication are also used 
in part for the thesis. The goal of my study was to characterize and investigate the role of PHD3 in BMDM. 
In my experiments I used a conditional PHD3-deficient mouse model. The PHD3 knockout (referred to as 
PHD3
-/-
) mouse model was established by using PHD3
flox/flox
 mice, in which exon 2 of the PHD3 gene was 
flanked by loxP sites (Fig. 9). PHD3
flox/flox
 mice were crossed with M lysozyme Cre (LysMCre) mice which 
express the Cre recombinase under the control of the mouse lysozyme M gene regulatory region. This 













 mice have a reduced PHD3 expression 
in the myeloid cell lineage (monocytes, mature macrophages and granulocytes). 
                     
 
Figure 9: Myeloid-specific PHD3-deficient mouse line generation scheme 
Myeloid-specific PHD3-deficient mice were generated by crossing PHD3
flox/flox
 mice, in which exon 2 is flanked by loxP (flox) sites, 
with mice expressing the Cre recombinase under control of the lysozyme (LysM) gene regulatory region.  
 
Littermates were genotyped by performing PCRs with gDNA (Fig. 10) to confirm the presence of the loxP 
sites within the PHD3 gene (product size 840 bp and 400 bp in floxed and wt mice, respectively) and to 
determine the presence or absence of the Cre recombinase (product size 700 bp and 350 bp in cre 





Figure 10: Genotype determination 















 x LysM Cre
+/-
 mice were 
genotyped by performing PCRs with 
gDNA. Representative PCRs of mice with 
different genotypes are shown.  
 
 
3.2 Consequences of a PHD3 deficiency in macrophages for 
their differentiation and morphology 
 
It has been shown earlier by Kiss et al that the macrophage differentiation process of bone marrow cells 
was altered in BMDM isolated from constitutive PHD3 knockout mice over time (Kiss et al., 2012). To 
investigate if the conditional knockout of PHD3 also influences the differentiation of macrophages over 
time, bone marrow cells of both genotypes, i.e. wt and PHD3
-/-
 were differentiated to mature macrophages 
with M-CSF conditioned medium. To quantify the differentiation efficacy of the macrophages over time, the 
cells were stained with anti-F4/80 and anti-CD11b antibodies and analyzed using flow cytometry.  F4/80 is 
a marker for mature macrophages. CD11b marks cells that originated from the monocyte population and 
neutrophils. The macrophage differentiation process of bone marrow cells was indeed altered in wt and 
PHD3
-/-
 cells over time. PHD3
-/- 
bone marrow cells differentiated at earlier time points, i.e. day 3, 4 and 5, 
demonstrated by elevated numbers of F4/80 and CD11b positive cells (Fig. 11). 8 days after starting the 





Figure 11: Differentiation of wt and PHD3-/- BMDM over time 
Macrophages were differentiated from bone marrow cells of 8 - 12 weeks old wt and PHD3
-/-
 mice using M-CSF containing medium 
over 3-8 days.  PHD3-deficiency in myeloid cells promoted the differentiation of BMDM as shown by F4/80 and CD11b-stainings 
using FACS analysis. Shown are mean values ± SD, n=3, *p<0.05, **p<0.01. 
 
To study if the knockout of PHD3 in macrophages affects the morphology of the macrophages, cell 
staining was performed.  Cells isolated from both wt and PHD3
-/-
 mice were differentiated over 3 or 8 days 
with M-CSF conditioned medium. After 3 or 8 days of differentiation the cells were stained with phalloidin 
(F-actin marker) and DAPI (nucleus marker) (Fig. 12). The cells were then imaged using a fluorescence 
microscope for morphological differences. Bone marrow cells of both genotypes differentiated to mature 
macrophages and showed no obvious difference in cell morphology after 3 or 8 days of differentiation. In 
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Figure 12: Morphology of wt and PHD3-/- BMDM during differentiation 
Wt and PHD3
-/-
 BMDM were differentiated for 3 or 8 days with M-CSF conditioned medium. Subsequently, cells were stained with 
phalloidin and DAPI. PHD3-deficiency in myeloid cells did not affect the morphology of the cells. 
3.3 Consequences of PHD3-deficiency for macrophage gene 
expression 
 
To confirm the knockout of PHD3 and gain insight into the knockout efficiency, qRT-PCRs were 
performed. Wt and PHD3
-/-
 BMDM were incubated in normoxia (20% O2) or hypoxia (1% O2) for 24 hrs. 
Subsequently, the mRNA expression level of PHD3 was analyzed (Fig. 13).  The hypoxic induction of 
PHD3 is in line with the literature and is part of a negative feedback mechanism to limit the acute hypoxic 
response (Stiehl et al., 2006). PHD3
-/-
 BMDM showed a 75% and 60% reduction of PHD3 RNA levels in 
normoxia and hypoxia respectively. Thus, in hypoxia the knockout efficiency was still maintained even 
after the induction of PHD3 
 
Figure 13: PHD3 mRNA expression of wt and PHD3-/- macrophages 
PHD3 RNA levels were quantified in BMDM isolated from wt and PHD3
-/-
 
mice and exposed to 20% or 1% O2 for 24 hrs. Shown are mean values ± 




The mRNA expression of the other two isoforms of PHDs, i.e. PHD1 and PHD2 was investigated to 
analyze if the knockout of PHD3 affects their expression. qRT-PCR was performed with samples obtained 
from wt and PHD3
-/-
 BMDM, which were incubated in normoxia (20% O2) or hypoxia (1% O2) for 24 hrs 
(Fig. 14). Comparable to PHD3, PHD2 is inducible in hypoxia. This effect was observed in wt and PHD3
-/-
 
BMDM. In none of the conditions analyzed there was a difference when comparing PHD1 and PHD2 RNA 




Figure 14: mRNA expression of PHD1 and PHD2 of wt and PHD3-/- macrophages 
PHD1 and PHD2 RNA levels were quantified by qRT-PCR in wt (black bars) and PHD3
-/-
 (white bars) BMDM, which were incubated 
for 24 hrs in normoxia (20% O2) or hypoxia (1% O2). Shown are mean values ± SD, n=3, *p<0.05, ***p<0.001. 
 
Western blots were performed to confirm the data obtained by analyzing mRNA expression of PHD2 and 
PHD3 at the protein level. Wt and PHD3
-/-
 BMDM were cultured under 20% and 1% O2 conditions for 24 
hrs. Expression of PHD3, PHD2 and HIF-1α was analyzed at protein level both in normoxic and hypoxic 
conditions (Fig. 15). PHD1 was not analyzed based on the lack of a suitable antibody. In line with the RNA 
data, at protein level a significant decrease of PHD3 was seen in the PHD3
-/-
 BMDM. This difference was 
more obvious after incubating the cells for 24 hrs at hypoxia compared to normoxia based on the hypoxic 
induction of PHD3. PHDs regulate the stability of HIF-1 and HIF-2. A knockout of PHD2 alone is indeed 
sufficient to stabilize HIF in normoxia. Knockout of PHD3 in the BMDM did however not result in a 




three proteins was not altered in the PHD3
-/-
 BMDMs likewise indicating that the reduction of PHD3 
expression alone is not sufficient to induce HIF stabilization.  
 
  
Figure 15: Protein expression of PHD3, PHD2, HIF-1α and HIF-2α of wt and PHD3-/- 
BMDM  
BMDM were isolated from wt or PHD3
-/-
 (KO) mice. Cells were incubated for 24 hrs in normoxia 
(20% O2) or hypoxia (1% O2). Subsequently, cells were lysed and HIF-1α, PHD2, HIF-2α, PHD3 




3.4 HIF-dependent target gene expression is unchanged in 
PHD3-/- BMDM 
 
To further confirm that HIF stabilization and HIF activity were not affected by knocking out PHD3 the 
mRNA expression of HIF target genes were investigated. To this end, wt and PHD3
-/-
 BMDM were 
incubated in normoxia (20% O2) or hypoxia (1% O2) for 24 hrs and the mRNA expression levels of the HIF 
target genes pyruvate kinase M2 (PKM2), phosphofructokinase (Pfk) and pyruvate dehydrogenase 
kinase-1 (PDK-1) were quantified. The normoxic RNA expression as well as the hypoxic induction of these 
HIF target genes was unaltered in the PHD3
-/-
 BMDM (Fig. 16). These results indicate that knocking down 
PHD3 is not sufficient to affect HIF dependent pathways in BMDM. 
 
 












   
Figure 16: mRNA expression of HIF target genes of wt and PHD3-/- BMDM 
The expression of the HIF target genes PKM2, Pfk and PDK-1 on mRNA level was analyzed after cultivating BMDM for 24 hrs at 
20% O2 or 1% O2 by qRT-PCR. Shown are mean values ± SD, n=3, **p<0.01, ***p<0.001. 
To gain insight if there are any other differentially expressed genes in PHD3
-/-
 versus wt BMDM, an 
unbiased transcriptome screen was performed in collaboration with the Transkriptions Analyse Labor 
(TAL, University Medical Center Göttingen). BMDM were incubated in normoxia (20% O2) or hypoxia (1% 
O2). In the following unbiased transcriptome screen I could indeed not find any significantly differentially 
expressed gene comparing wt versus PHD3
-/-
 BMDM in normoxia and hypoxia (Fig. 17). There was as 
expected a whole set of RNAs, which were upregulated in hypoxia in wt and PHD3
-/-
 BMDM. This classical 
hypoxic response however was not altered by the knockout of PHD3.  
 
Figure 17: Volcano plot for differentially expressed genes under normoxia and hypoxia 
PHD3
-/-
 and wt BMDM, which were isolated from three independent mice for each genotype, were cultivated for 48 hrs at 20% O2 or 
1% O2. Subsequently, cells were lysed and RNA isolated. RNA samples were analyzed in a transcriptome microarray assay. The 




Among the RNAs which were identified to be upregulated in hypoxia there were classical HIF-target genes 
like Bnip3, Egln3, arginase etc. (Table 3.1). This analysis served as internal quality control for the screen. 
Table 3.1 List of genes, which were identified to be highly  
induced in hypoxia in wt BMDM 
Fold change 
Ppp1r3g protein phosphatase 1, regulatory (inhibitor) subunit 3G 7.82 
Rcor2 REST corepressor 2 5.30 
Ankrd37 ankyrin repeat domain 37 5.50 
Fam162a family with sequence similarity 162, member A 4.17 
Bnip3 BCL2/adenovirus E1B interacting protein 3 4.57 
Egln3 EGL nine homolog 3 (C. elegans) 6.28 
Egln3 EGL nine homolog 3 (C. elegans) 6.33 
Gipr gastric inhibitory polypeptide receptor 7.61 
Mboat2 membrane bound O-acyltransferase domain containing 2 5.54 
Prelid2 PRELI domain containing 2 4.86 
Rgs11 regulator of G-protein signaling 11 4.91 
Triobp TRIO and F-actin binding protein 5.55 
Mgarp mitochondria localized glutamic acid rich protein 8.33 
Ak4 adenylate kinase 4 6.15 
Bnip3 BCL2/adenovirus E1B interacting protein 3 4.31 
Gm5486 predicted gene 5486 4.36 
Smtnl2 smoothelin-like 2 7.31 
Ero1l ERO1-like (S. cerevisiae) 4.55 
Ppp1r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C 5.10 
Prr15 proline rich 15 5.54 
Adm adrenomedullin 4.28 
Skint3 selection and upkeep of intraepithelial T cells 3 4.49 
Slc16a3 solute carrier family 16 (monocarboxylic acid transporters), member 3 4.17 
Glt25d2 glycosyltransferase 25 domain containing 2 4.48 
Bnip3 BCL2/adenovirus E1B interacting protein 3 4.68 
Arg1 arginase, liver 8.29 
Xpnpep2 X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound 5.23 
Gm3367 predicted gene 3367 6.12 
Muc2 mucin 2 6.05 
Dapk2 death-associated protein kinase 2 4.55 
Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 5.25 
F13a1 coagulation factor XIII, A1 subunit 5.63 
Ak4 adenylate kinase 4 4.67 
Nos2 nitric oxide synthase 2, inducible 4.02 
Nrbp2 nuclear receptor binding protein 2 4.29 




Sh3gl3 SH3-domain GRB2-like 3 4.22 
Kbtbd11 kelch repeat and BTB (POZ) domain containing 11 4.21 
Apln apelin 4.11 
Plekha6 pleckstrin homology domain containing, family A member 6 4.34 
 
Additionally, I was able to identify a cluster of small G-protein related factors, which were altered in 
hypoxia in both genotypes (Table 3.2). The hypoxic regulation of these factors was not described so far. 
The Rho GTPase activating protein 29 (ArhGAP29) was found to be induced in hypoxia. It is markedly 
involved in controlling Rho activity and cytoskeletal dynamics in hypoxia. This finding was in the meantime 
verified in other cell lines by members of the Institute of Cardiovascular Physiology and initiated an 
independent project on the hypoxic regulation of ArhGAP29 and the implication of this for the regulation of 
the actin cytoskeleton.   
Table 3.2 
 
List of Rho-GTPase associated genes, which were identified to be 
differentially expressed in hypoxia 
Arhgap19 Rho GTPase activating protein 19 
Arhgdig Rho GDP dissociation inhibitor (GDI) gamma 
Arap2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 
Srgap3 SLIT-ROBO Rho GTPase activating protein 3 
Arhgap29 Rho GTPase activating protein 29 
Kalrn kalirin, RhoGEF kinase 
Arhgap28 Rho GTPase activating protein 28 
Arhgap15 Rho GTPase activating protein 15 
Fgd2 FYVE, RhoGEF and PH domain containing 2 
Arhgap21 Rho GTPase activating protein 21 
Arhgap27 Rho GTPase activating protein 27 
Plekhg6 pleckstrin homology domain containing, family G (with RhoGef domain) member 
6 
Arhgef19 Rho guanine nucleotide exchange factor (GEF) 19 
Syde1 synapse defective 1, Rho GTPase, homolog 1 (C. elegans) 
 
 
It has already been reported that apart from HIF under specific circumstances PHDs can regulate 
additionally NFB activity (Scholz et al., 2013; Cummins et al., 2006). To test, if the NFB response was 
altered as a consequence of the PHD3 knockout, wt and PHD3
-/-
 BMDMs were cultured under control and 




cells were lysed and NFB activity was analyzed. The assay revealed that in the PHD3
-/-
 BMDM there was 
no obvious difference in NFB activity compared to the wt cells under resting conditions or after serum 
starvation (Figure 18). After stimulation with LPS, however, the wt BMDM demonstrated higher NF-kB 
activity compared to the PHD3
-/-
 BMDM, which is in line with the above referenced work that has 
uncovered mechanisms by which hypoxia modulates the activation of NFB through decreased oxygen-




Figure 18: NFκB activity in wt and PHD3-/- macrophages 
PHD3
-/-
 and wt BMDM were cultured with or without serum for 24 
hrs or stimulated with 100 ng LPS for 12 hrs. Subsequently 
NFB activity was analyzed. As a positive control for the NFB 
activity assay a cell extract of HeLa cells treated with LPS, was 
used. Shown are mean values ± SD, n=3, **p<0.01. 
 
 
3.5 Macrophage polarization is unaffected in PHD3-/- BMDM 
 
Macrophages display remarkable plasticity and can change their phenotype upon stimulation (Mosser and 
Edwards, 2008). The most prominent macrophage populations are the so called M1 and M2-polarized 
macrophages. M1-polarized macrophages are pro-inflammatory and tissue destructive, whereas M2-
polarized macrophages are anti-inflammatory and involved in tissue remodelling as well as angiogenesis. 
Macrophage polarization can be affected by HIF-1 and HIF-2 (Takeda et al., 2010) (Takeda et al). To 
analyze if PHD3 affects macrophage polarization we treated wt and PHD3
-/-
 BMDM, which were 
differentiated for 8 days, with LPS and the TH1 cytokine IFN or the TH2 cytokine IL-4 to functionally 
characterize M1 and M2-polarization, respectively (Fig. 19 a and b). Successful M1 and M2-polarization 
after stimulation was verified by increased RNA levels of the M1 markers IL-6, iNOs and TNF as well as 
the M2 markers arginase, Ym-1 and Fizz, respectively. Expression levels of the M1 and M2 marker RNAs 
were not different comparing wt and PHD3
-/-








Figure 19: Macrophage polarization of PHD3-/- macrophages 
 PHD3
-/-
 and wt BMDM, which were differentiated for 8 days, were stimulated with LPS+INFγ (M1-polarization) or IL-4  (M2-
polarization) for 6 hrs, subsequently RNA levels for the (a) M1-polarization markers IL-6, iNos and TNFα (b) the M2-polarization 
markers Arginase, Ym-1 and FIZZ were quantified by qRT-PCR. Shown are mean values ± SD, n=3, **p<0.01, ***p<0.001. 
 
The above findings were further confirmed at protein level, by investigating the concentrations of IL-6 and 
TNF in the cell culture supernatants. Similar to the above described experiments wt and PHD3
-/-
 BMDM, 
which were differentiated for 8 days, were treated with LPS and the TH1 cytokine IFN. Then the culture 
supernatant was harvested and FACS analyses were performed to investigate the cytokine 
concentrations. IL-6 and TNF protein levels were significantly induced in the cell culture supernatants 
after stimulation with LPS+IFN (Fig. 20). In line with the RNA data, the concentrations of IL-6 and TNF 
were not different comparing wt and PHD3
-/-
 BMDM. 





Figure 20: IL-6 and TNFα secretion of PHD3-/- macrophages 
PHD3
-/-
 and wt BMDM were stimulated with LPS+INFγ (M1-polarization) or IL-4  (M2-polarization) for 6 hrs, subsequently protein 




3.6 PHD3-/- BMDM are protected from apoptotic cell death 
 
PHD3 has been associated with cell survival decisions in the context of apoptosis in various cell and 
animal models (Bishop et al., 2008) (Wottawa et al., 2010) (Jaakkola and Rantanen, 2013). Therefore, we 
next determined the role of PHD3 in macrophage cell-survival pathways. To analyze, if apoptosis is 
altered in the PHD3
-/-
 BMDM I deprived cells for 48 hrs from serum (Fig. 21). Starving the cells induced 
apoptosis in wt BMDM as determined by quantifying TUNEL positive cells which marks the fragmented 
DNA/damaged DNA in the cell. Most interestingly in PHD3
-/-
 BMDM, apoptosis was just slightly induced 
under starvation compared to wt cells. Thus, the PHD3
-/-
 macrophages were significantly protected under 















 and wt BMDM were cultivated with or without serum (starved) 
for 48 hrs, subsequently the number of apoptotic cells was quantified 
by TUNEL assay. A knockout of PHD3
 
in macrophages significantly 
protects the cells from apoptosis when serum starved. Shown are 
mean values ± SD, n=3, *p<0.05, ***p<0.001. 
 
 
The above obtained result was further confirmed by Annexin V assays. With this assay the membrane 
integrity of the cells is analyzed to investigate the amount of apoptotic cells. Both wt and PHD3
-/-
 BMDM 
were cultured for 48 hrs in control or starved conditions. Afterwards the cells were stained with an anti-
Annexin V antibody and were analyzed using FACS. In line with the TUNEL assay, the Annexin V assay 
showed that starving the cells induced apoptosis in wt BMDM whereas PHD3
-/-
 macrophages were 
significantly protected. (Fig. 22) 
 
Figure 22: Annexin V staining of wt and PHD3-/- BMDM 
PHD3
-/-
 and wt BMDM were cultivated with or without serum (starved) for 48 hrs, 
subsequently the number of Annexin V positive cells were quantified. PHD3
-/- 
in 
macrophages significantly protects the cells from apoptosis when serum starved. 
Shown are mean values ± SD, n=6, **p<0.01, ***p<0.001. 
 
The partial protection of PHD3
-/- 
BMDM after serum starvation was further confirmed by performing 
Calcein-AM assays to see if the anti-apoptotic effect is reflected in altered viability of the cells. Indeed, 
PHD3
-/-
 BMDM had a higher viability under control conditions and after 48 hrs of starvation compared to wt 









Figure 23: Viability assay wt and PHD3-/- BMDM 
PHD3
-/-
 and wt BMDM were cultivated with or without serum (starved) for 48 
hrs and then the cell viability was determined using the Calcein-AM viability 
assay. PHD3
-/- 
BMDM showed significantly increased viability both in control 
and starved conditions. n=6, mean ± SD, **p<0.01, ***p< 0.001. 
 
 
To analyze if the PHD3 mediated anti-apoptotic effect is just limited to serum deprivation, macrophages 
were cultured in the presence of the known pro-apoptotic agents S-nitroso-N-acetylpenicillamine (SNAP, 
100 µM), staurosporine (stauro, 500 nM) or LPS (5 or 10 µg/mL) and rates of apoptosis were determined 
(Fig. 24). The result obtained showed that in the presence of the pro-apoptotic agents tested PHD3
-/- 
macrophages were significantly protected as compared to the respective wt BMDM. 
 
Figure 24: Annexin V assay staining of wt and PHD3-/- BMDM with apoptotic inducers treatment 
The number of Annexin V-positive cells were quantified after cultivating PHD3
-/-
 and wt BMDM with or without (starved) serum for 48 
hrs or treating the cells with 100 µM SNAP, 500 nM stauro or 5-10 µg/mL LPS for 12 hrs. n=5, mean ± SD, ***p< 0.001. 
 
In addition to the treatment with pro-apoptotic agents in normoxia the PHD3-mediated phenotype was also 
confirmed under hypoxic conditions. To analyze the impact of hypoxia on serum starvation induced 
apoptosis I exposed wt and PHD3
-/-




starvation. Both wt and PHD3
-/-
 BMDM were cultured for 48 hrs in control or starved conditions at 20% O2 
and 1% O2 (Fig. 25).Then TUNEL assays were performed and the cells were analyzed to determine the 
amount of apoptotic cells. In normoxia as well as in hypoxia PHD3
-/-
 BMDM were significantly protected 
from apoptosis compared to wt macrophages. In hypoxia however, the protective effect was slightly but 
not significantly weakened in the PHD3
-/-
 BMDM. This correlates to the hypoxic induction of PHD3 as 




Figure 25: TUNEL assay of wt and PHD3-/- BMDM comparing normoxic versus hypoxic effects 
 TUNEL-positive cells were quantified after cultivating PHD3
-/-
 and wt BMDM with or without serum (starved) for 48 hrs at 20% O2 or 
1 % O2.  n = 3, mean ± SD, **p<0.01, ***p< 0.001. 
 
To gain insight into the apoptotic phenotype an unbiased transcriptome analysis was performed. Using a 
mouse genome array we compared RNA transcript abundance in wt and PHD3
-/-
 BMDM, which were 
deprived of serum for 48 hrs. Among the transcript changes, which differed in their extent in response to 
the serum deprivation between wt and PHD3
-/-
 BMDM, I identified in total 26 transcripts that were up-







Table 3.3: Genes of the RNAs, which were identified to be induced and differentially expressed comparing 
wt and PHD3
-/-
 BMDM after serum starvation 
Gene ID Symbol Description 
56473 Fads2 fatty acid desaturase 2 
17392 Mmp3 matrix metallopeptidase 3 
14990 H2-M2 histocompatibility 2, M region locus 2 
26360 Angptl2 angiopoietin-like 2 
76009 5830415G21Rik RIKEN cDNA 5830415G21 gene 
14858 Gsta2 glutathione S-transferase, alpha 2 (Yc2) 
246049 Slc36a2 solute carrier family 36 (proton/amino acid symporter), 
member 2 
14238 Foxf2 forkhead box F2 
68027 Tmem178 transmembrane protein 178 
18548 Pcsk1 proprotein convertase subtilisin/kexin type 1 
17384 Mmp10 matrix metallopeptidase 10 
20408 Sh3gl3 SH3-domain GRB2-like 3 
19746 Rhd Rh blood group, D antigen 
13051 Cx3cr1 chemokine (C-X3-C) receptor 1 
19124 Procr protein C receptor, endothelial 
15490 Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 
207683 Igsf11 immunoglobulin superfamily, member 11 
16197 Il7r interleukin 7 receptor 
79201 Tnfrsf23 tumor necrosis factor receptor superfamily, member 23 
56018 Stard10 START domain containing 10 
228543 Rhov ras homolog gene family, member V 
217265 Abca5 ATP-binding cassette, sub-family A (ABC1), member 5 
12614 Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo 
homolog, Drosophila) 
627270 Gm10055 predicted gene 10055 
320121 6720473M08Rik RIKEN cDNA 6720473M08 gene 





Table 3.4: Genes of the RNAs, which were identified to be reduced and differentially expressed 
comparing wt and PHD3
-/-
 BMDM after serum starvation 
Gene ID Symbol Description 
20511 Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), 
member 2 
69590 Gpx8 glutathione peroxidase 8 (putative) 
12035 Bcat1 branched chain aminotransferase 1, cytosolic 
17472 Gbp4 guanylate binding protein 4 
64074 Smoc2 SPARC related modular calcium binding 2 
20350 Sema3f sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3F 
109264 Me3 malic enzyme 3, NADP(+)-dependent, mitochondrial 
241230 St8sia6 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 
105785 Kdelr3 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention 
receptor 3 
16429 Itln1 intelectin 1 (galactofuranose binding) 
12478 Cd19 CD19 antigen 
12837 Col8a1 collagen, type VIII, alpha 1 
69675 Pxdn peroxidasin homolog (Drosophila) 
20692 Sparc secreted acidic cysteine rich glycoprotein 
20204 Prrx2 paired related homeobox 2 
12831 Col5a1 collagen, type V, alpha 1 
22402 Wisp1 WNT1 inducible signaling pathway protein 1 
98932 Myl9 myosin, light polypeptide 9, regulatory 
18054 Ngp neutrophilic granule protein 
 
 
3.7 Confirming the differential expression of genes by qRTPCR 
 
The transcriptome screen revealed 45 genes to be differentially expressed in starved PHD3
-/- 
compared to 
wt BMDM. To further check the quality of the screen, qRT PCR analyses of some of the identified genes 
were done (Fig. 26). The RNA of the proprotein convertase subtilisin/kexin type 1 (Pcsk1) and the protein 
C receptor (Procr) were found to be induced by serum starvation. This was verified by the independent 
qRT-PCR analyses. Additionally, the differential induction of Pcsk1 and Procr comparing wt and PHD3
-/-
 
BMDMs was verified. Whereas the induction of Pcsk1 after serum starvation was significantly higher in the 
wt BMDMs compared to the PHD3
-/-




of WNT1 inducible signaling pathway protein (WISP1) and paired related homeobox 2 (Prrx2), which were 







Figure 26: qRT-PCR analysis confirming the differential expression of candidate genes  
PHD3
-/-
 and wt BMDM were cultivated with or without serum for 48 hrs (starved). Subsequently genes from the transcriptome screen 
Pcsk1, WISP1, Procr and Prrx2 mRNA were analyzed by qRT-PCR. n = 6, mean ± SD, *p<0.05, ***p<0.001.  
 
3.8 Angptl2 is differentially expressed and involved in the 
differential apoptotic response 
 
Pro- and anti-apoptotic pathways can be induced by secreted factors. To test, if secreted factors are 
involved in the differential induction of apoptosis of wt and PHD3
-/-
 BMDMs, I performed experiments with 
wt or PHD3
-/-
 conditioned medium. Treating wt and PHD3
-/-
 BMDM during serum deprivation with 
conditioned medium of serum-deprived PHD3
-/-
 and wt cells, respectively, revealed a loss of the anti-
apoptotic phenotype in the PHD3
-/-
 BMDM (Fig. 27). This indicated that at least in part a secreted factor is 





Figure 27: wt conditioned medium induces apoptosis of PHD3-/- macrophages 
PHD3
-/-
 and wt BMDM were cultivated with or without serum in total for 48 hrs. After 24 hrs the medium was exchanged across the 
genotypes and cultured for 24 additional hrs. Induction of apoptosis was compared using Annexin V staining and FACS analysis. n = 
5 mean ± SD, **p<0.01, ***p< 0.001. 
 
The result shown in Fig. 27 made me to go back to the transcriptome screen and look specifically for 
soluble/secreted factors. Further gene cluster analysis of the 45 genes identified in the above described 
transcriptome array revealed a cluster of genes (i.e. Angptl2, Col8A1, Col5A1, KDELR3, MYL9 and 
PXDN), which are known to be co-regulated. Angiopoietin-like proteins (Angptls) are secreted proteins, 
which like angiopoietin itself have an N-terminal coiled-coil domain and a C-terminal fibrinogen-like 
domain. So far 7 Angptls have been identified. None of these bind to the angiopoietin receptor Tie2 or to 
the homologous Tie1 receptor. Angptl2 has been found to affect vascular cells and monocytes. In line 
Angptl2 functions as a chronic inflammatory mediator in obesity (Tabata et al., 2009), atherosclerotic 
disease (Tabata et al., 2009), rheumatoid arthritis (Tabata et al., 2009) (Okada et al., 2010), and cancer 
(Endo et al., 2012). Although the receptor signaling of Angptl2 is not fully understood, some of these 
biological effects seem to be at least in part mediated via binding to 51 integrin and the paired 
immunoglobin-like receptor B (PirB) or human orthologue immunoglobin-like receptor B2 (LILERB2)  
(Tabata et al., 2009). The differential expression of Angptl2 in wt and PHD3
-/-
 BMDM after serum 
starvation was verified by independent qRT-PCR (Fig. 28). To analyze, if hypoxia affects the expression of 
Angptl2, I additionally exposed the wt and PHD3
-/-
 BMDM during serum starvation to 20% O2 or 1% O2. 
Exposure of the macrophages to hypoxia during starvation significantly increased the expression of 












 and wt BMDM were cultivated with or without (starved)   
serum for 48 hrs in normoxia (20% O2) or hypoxia (1% O2). 
Subsequently Angiopoietin-like protein 2 (Angptl2) mRNA was 




In the above described experiments I was able to show that the protection from apoptosis in the PHD3
-/-
 
BMDM is not just restricted to the induction of apoptosis after serum starvation. SNAP and stauro 
treatment resulted in an altered induction of apoptosis in the PHD3
-/-
 BMDM likewise. Therefore, Angptl2 
RNA levels were quantified in wt and PHD3
-/-
 BMDM after treatment with SNAP or stauro to proof that the 
altered Angptl2 response of the PHD3
-/-
 BMDM does occur after treatment with several different apoptotic 
stimuli. Serum starvation was included in this experiment as positive control. Like in starvation, the 
Angptl2 RNA levels were less in the PHD3
-/-
 BMDM compared to wt cells after SNAP and stauro treatment 








 and wt BMDM were cultivated with or without serum 
(starved) or treated with 100 µM S-nitroso-N-acetylpenicillamine 
(SNAP) or 500 nM staurosporine (stauro). Subsequently 
Angiopoietin-like protein 2 (Angptl2) mRNA was analyzed. n = 6, 
mean ± SD, *p<0.05, **p<0.01, ***p< 0.001. Serum starvation was 






The differential expression of Angptl2 in wt and PHD3
-/-
 BMDM was verified at protein level using an 
ELISA. For this wt and PHD3
-/-
 BMDM were cultured for 48 hrs both in control and starved conditions. The 
supernatants were harvested to estimate the Angptl2 concentration in these samples. In line with the 
mRNA data the Angptl2 protein concentration was less in PHD3
-/-
 BMDM cell culture supernatants 








 and wt BMDM were cultivated with or without (starved) 
serum for 48 hrs. Subsequently, cell culture supernatants were 
analyzed for Angiopoietin-like protein 2 (Angptl2) protein levels 
by ELISA. n = 6, mean ± SD,   **p<0.01. 
 
The function of Angptl2 in macrophages is not fully described so far. Moreover, there were at the time no 
data available, if Angptl2 can affect apoptosis of macrophages. Therefore I analyzed in cooperation with 
Prof. Y. Oike (Department of Molecular Genetics, Kumamoto University, Japan) the induction of serum 
starvation-induced apoptosis in wt and Angptl2 knockout (Angptl2
-/-
) BMDM. The group of Prof. Y. Oike 
was able to produce Angptl2
-/-
 mice in the past (Tabata, Kadomatsu et al. 2009). These animals were 
used for the analyses. In line with the anti-apoptotic effect and diminished expression of Angptl2 in the 
PHD3
-/-
 cells, BMDM, which were isolated and differentiated from previously described Angptl2
-/-
 mice, 
exhibited less AV-positive cells after serum starvation or stauro treatment (Fig. 31). 
 
 
Figure 31: Effect of recombinant Angptl2 on wt BMDM 
Angptl2
-/-
 and wt BMDM were cultivated with or without serum 
(starved) for 48 hrs or exposed to 500 nM staurosporine (stauro) 
for 12 hrs. Subsequently, induction of apoptosis was compared 





3.9 Treatment of BMDM with recombinant Angptl2 
 
In the final experiments I tested, if reconstitution of the diminished Angptl2 response in the PHD3 deficient 
macrophages would rescue the apoptosis phenotype (Fig. 32). Therefore 2 or 4 µg recombinant Angptl2 
was added to wt or PHD3
-/-
 BMDM during serum starvation. 48 hrs later, the number of Annexin V-positive 
cells was analyzed. Adding the recombinant Angptl2 to the PHD3
-/- 
BMDM indeed reversed the anti-
apoptotic effect demonstrating that Angptl2 is at least partially involved in the PHD3-mediated response 
towards an apoptotic stimulus. Most interestingly, wt BMDM did not respond with increased apoptosis 
after adding 2 µg recombinant Angptl2 under resting conditions or after starvation. After adding 4 µg 
recombinant Angptl2 there was even an anti-apoptotic effect after starvation These data indicate that not 
only the production of Angptl2 is altered in PHD3
-/-
 BMDM but also the cellular response to it.  
 
. 
Figure 32: Treatment of wt and PHD3-/- BMDM with recombinant Angptl2 
PHD3
-/-
 and wt BMDM were cultivated with or without serum (starved) in total for 48 hrs. Recombinant Angiopoietin-like protein 2 
(Angptl2) was added as indicated. Induction of apoptosis was analyzed by Annexin V staining and FACS analysis. n = 5, mean ± SD, 
**p<0.01, ***p<0.001. 
As described above, 51 and PirB were previously identified to bind to Angptl2. This does not include 
that this orphan ligand does not signal via other receptors. Since the results with the recombinant Angptl2 
indicate that the response towards it might be altered in the PHD3
-/-




expression of 51 and PirB in wt versus PHD3
-/-
 BMDM (Fig. 33). Both receptors could be identified by 





Figure 33: Expression of Angptl2 receptors in wt and PHD3-/- 
macrophages 
51 and PirB receptor expression was analyzed in PHD3
-/-
 (white bars) 
























Adequate supply of oxygen is an essential prerequisite for living organisms. Insufficient oxygen availability 
is known as hypoxia. The oxygen sensors PHD 1-3 sense hypoxia and respond to it by regulating the 
master transcription factor HIF by prolyl hydroxylation at specific prolyl residues, marking the HIFα subunit 
for proteasomal degradation. HIF-1α is predominantly hydroxylated by PHD2 and HIF-2α by PHD3. 
Although the PHD shares many similarities, they differ in enzymatic activity, expression pattern and 
specific function.  Among the three PHD isoforms, the constitutively expressed PHD2 is the main regulator 
of HIFα stability in normoxia. In contrast PHD3, which is induced under hypoxia, creates a feedback loop 
to further regulate HIFα under hypoxia and upon reoxygenation. To gain further insight into the specific 
function of different PHD isoforms is important for the ongoing development of small molecule PHD 
inhibitors that are currently tested in preclinical and clinical trials for the treatment of anemia and for 
cytoprotection. Interfering with any of these PHD isoforms might alter the response of the immune system. 
It has been shown earlier that, tissue inflammation can lead to hypoxia, resulting in stabilization of HIF-1α 
or HIF-2α in the inflamed tissues. Therefore, the interplay and the close connection between PHDs and 
immunomodulators have to be studied in more detail. Additionally, hypoxia and HIFs are known to be 
crucial modulators of systemic inflammation (Imtiyaz et al., 2010; Zinkernagel et al., 2007). PHDs are also 
known to be expressed in leukocytes and macrophages (Peyssonnaux et al., 2005). Myeloid-derived cells 
are rapidly mobilized to hypoxic areas of ischemic tissues and are acknowledged to contribute to post-
ischemic regeneration. They adapt rapidly through the activation of the HIF signaling pathway. Targeting 
the PHD/HIF-pathway in the myeloid cell lineage would therefore be a promising strategy to investigate 
the isoform and cell specific function of PHDs. In the past few years the importance of myeloid cells for 
angiogenesis and neovascularization in hypoxia-associated disorders, like arterial occlusion or 
atherosclerotic plaques, became evident. Loss of PHD3 is known to enhance the innate immune response 
(Kiss et al., 2012) and regulate the life span of neutrophils under hypoxia (Walmsley et al., 2011). The 
specific role of PHD3 in macrophages however was less explained so far. For this purpose a myeloid-





4.1 HIF target gene expression is unchanged in PHD3-/- BMDM 
 
To investigate the role of PHD3 in BMDMs myeloid-specific PHD3
-/-
 mice were used. The myeloid-specific 
mouse line was generated using the conditional Cre/loxP knockout strategy. The Cre recombinase was 
expressed under the control of LysM promoter. Through this conditional knockout strategy I generated 
BMDMs with a knockout efficiency of roughly 75% (Fig. 13). The motive of using a conditional knockout is 
that it more or less resembles the pharmacological inhibition of the PHD enzymes. PHD enzymes are 
currently tested for their potential to be used as drug targets to stimulate HIF-dependent gene expression 
(Myllyharju, 2008).  This strategy is developed for applications in the context of ischemia tissue protection 
and severe anemia (Katschinski, 2009). The strong hypoxic induction of PHD3 is even conserved in 
BMDMs which has already been described in myeloid cells in several publications (Rohrbach et al., 2005; 
Appelhoff et al., 2004; Walmsley et al., 2011) .  
Knocking out PHD3 in myeloid cells affects neither the morphology nor the differentiation of 8 days 
differentiated BMDMs (Fig. 11 and Fig. 12).  However the process of differentiation was altered in PHD3
-/-
 
BMDMs observed by F4/80 and CD11b staining (Fig. 11). The PHD3
-/-
 BMDM showed a higher 
differentiation efficiency over time. This is in line with an earlier study (Kiss et al., 2012) analyzing 
constitutive PHD3
-/-
 BMDMs. My results confirmed that PHD3 might be involved in the differentiation 
process of macrophages. 
The PHD3
-/-
 BMDM do not alter the expression of the other HIF-regulating isoforms of PHDs, i.e. PHD1 
and PHD2, suggesting that no compensatory effect occurs (Fig. 14). In addition the knockout does not 
show increased HIF-1α and HIF-2α protein levels in normoxia and hypoxia (Fig. 15). Further, HIF target 
gene expression in the knockout macrophages do not seem to be regulated both in normoxic and hypoxic 
conditions, but as expected hypoxic induction of HIF target genes was confirmed (Fig. 16). Even in the 
unbiased transcriptome screen, I could indeed not find any significantly differentially expressed HIF target 
gene in the PHD3
-/-
 BMDM (Fig. 17). My results show that knocking out PHD3 in myeloid cells is not 





4.2 Macrophage polarization is unaffected in PHD3-/- BMDM 
 
Plasticity and diversity are the known hallmarks of the monocyte-macrophage differentiation pathway. 
Macrophages have huge versatility and can change their phenotype upon stimulation (Mosser and 
Edwards, 2008). It has been described in the literature that macrophages can differentiate into two 
subpopulations, which carry out distinct but time overlapping functions. These subpopulations can be 
broadly categorized as classically activated macrophages (M1) which consist of the pro-inflammatory 
macrophage subset, induced by interferon-γ and/or LPS and alternatively activated macrophages (M2) 
which consist of an anti-inflammatory macrophage subset induced by exposure to IL-4. M1 polarized 
macrophages are tissue destructive and remove the damaged tissue whereas M2 polarized macrophages 
induce tissue remodeling and angiogenesis (Fernando et al., 2014; Mosser and Edwards, 2008). The 
ability of macrophages to reprogram their function blurs in a way the distinction between innate and 
adaptive immune response. Moreover, evidence shows that the orchestration of macrophage function and 
polarization has a key role in different pathological conditions (Mantovani et al., 2004).   
Literature suggests that both HIF-1α and HIF-2α affect macrophage polarization. It is known that hypoxia 
can lead to macrophage inflammatory functions, e.g the production of cytokines by macrophages 
increases under hypoxia. LPS treatment induces stabilization of HIFα in macrophages (Frede et al., 2006; 
Takeda et al., 2010). It has been shown that 5 day differentiated constitutively knocked out PHD3 
macrophages are M1 polarized (Kiss et al., 2012). In contrast to this, my quantitative real-time PCR 
analysis showed no significant difference in induction of either M1 or M2 markers in PHD3
-/-
 macrophages 
(Fig. 19), nor does my protein expression analysis showed any difference in induction of cytokines upon 
exposure LPS, IFN and IL-4 in PHD3
-/-
 macrophages (Fig. 20). This suggests, that 8 days differentiated 
myeloid specific PHD3
-/-








4.3 NFκB activity is unaffected in PHD3-/- BMDM 
 
NFκB regulates the expression of pro-inflammatory molecules including cytokines and chemokines 
(Balkwill and Mantovani, 2001). PHDs have been shown to impact in the regulation of NFκB (Cummins et 
al., 2006a). It has been demonstrated that PHDs are repressors of NFκB activity, via their potential to 
hydroxylate the IКB kinase (Cummins et al., 2006). Further it has been described that PHD3 can associate 
with IKKβ independently of its hydroxylase function, thereby blocking the interaction between IKKβ and 
HSP90, which is required for IKKβ phosphorylation and release of NFκB (Xue et al., 2010). In addition, 
loss of function studies indicate that PHD3 serves as a co-activator of NFκB signaling activity (Fujita et al., 
2012). It was therefore then worthwhile to speculate that loss of PHD3 in my BMDMs might regulate NFκB 
activity (Hatada et al., 2000).  
In my study, I could show that PHD3
-/-
 BMDM do not have any obvious difference in NFκB activity 
compared to the wt cells (Fig. 18). Activation of macrophages with LPS treatment, however, showed less 
NFκB activity in PHD3
-/-
 BMDM, which is in line with the above referenced work that has uncovered 
mechanisms by which hypoxia modulates the activation of NFκB through decreased oxygen-dependent 
suppression of the key regulators of this pathway (Cummins et al., 2006; Scholz et al., 2013).  
 
4.4 PHD3 plays a pro-apoptotic role in BMDM 
 
A huge number of recent studies support the role of PHD3 in cell differentiation, survival, apoptosis, and 
metabolism. A clear role for PHD3 in neuronal apoptosis suggests that PHD3 mutations may be involved 
in the progression of neuronal malignancies. On the other hand, inhibition of PHD3 activity leads to 
survival of cancer cells (Lee et al., 2005). Apart from the role of PHD3 in other cell types, a major role of 
PHD3 on cell survival in myeloid cells is well described (Walmsley et al., 2011; Kiss et al., 2012). Also my 
analysis of cell survival in the conditional PHD3
-/-
 BMDM cells showed a pronounced apoptotic phenotype 
(Fig. 21). A major impact of PHD3 on cell survival is in line with the findings, that deficient PHD3 
neutrophils are not significantly altered regarding their pro-inflammatory function but regarding their 




PHD3-dependent regulation of KIF1β, HCLK2, SIVA and ATF-4 (Schlisio et al., 2008; Walmsley et al., 
2011; Xie et al., 2012; Koditz et al., 2007).  
My studies demonstrated that under stress condition such as starvation PHD3
-/-
 BMDMs have significantly 
lower DNA damage (Fig. 21). These results indicate that knocking out PHD3 in BMDM protects the cells 
from apoptosis under stress condition. To further confirm the impact of PHD3 on BMDM, I analyzed the 
membrane integrity of the cells (Fig. 22) and could confirm that PHD3 plays a pro-apoptotic role in 
BMDMs. Further I did experiments to investigate the BMDM viability, which showed an increased viability 
of the PHD3
-/- 
BMDMs (Fig. 23). Apart from the role of starvation for PHD3 mediated apoptosis my results 
also revealed that PHD3
-/-
 BMDM are significantly more protected to other apoptotic inducers such as 
staurosporine which causes ER stress or SNAP which causes oxidative stress (Fig. 24). Taken together, 
the above results demonstrate for the first time that PHD3 is involved in cell survival decisions in 
macrophages. 
 
4.5 Loss of PHD3 affects the expression of Angptl2 
 
To get an insight into the underlying molecular mechanism of the pro-apoptotic role of PHD3 in BMDMs, I 
performed a transcriptome screen in collaboration with the Transkriptions Analyse Labor (TAL, University 
Medical Center Göttingen). In the unbiased screen, none of the known target genes of PHD3-dependent 
regulation like KIF1β, HCLK2, SIVA and ATF-4 (Köditz et al., 2007; Schlisio et al., 2008; Walmsley et al., 
2011; Xie et al., 2012) were differentially regulated compared to wt BMDM. In the screen, 26 genes were 
found to be significantly induced under starvation (Table 3.3) and 19 genes were down regulated in a 
quantitatively different extent comparing wt versus PHD3
-/- 
BMDM (Table 3.4). Among these 45 genes, 
further gene cluster analysis revealed a cluster (i.e. Angptl2, Col8A1, Col5A1, KDELR3, MYL9 and 
PXDN), which is known to be co-regulated and is associated with the regulation of the secretory pathway.  
To further gain insight into the PHD3 mediated mechanism an experiment was performed involving the 
supernatant culture medium which contains the secreted proteins from the cells. The result revealed a 
loss of the anti-apoptotic phenotype in the PHD3
-/-




27). This indicated that at least in part a secreted factor is involved in the PHD3-mediated response 
towards an apoptotic stimulus.  
One candidate of the transcriptome screen, Angptl2 seemed to be a promising factor involved in 
regulating the PHD3 mediated response. A significant difference in the level of the secretory glycoprotein 
Angptl2 both at RNA and protein level was found (Fig. 28-30). Angiopoietin-like proteins are structurally 
similar to the angiopoietin group of proteins which contain a coiled-coil domain in the N-terminus and a 
fibrinogen-like domain in the C-terminus. Angiopoietin-like proteins represent a multi-functional family of 
secreted factors with structural similarity to angiopoietin, a molecule with pro-angiogenic function 
(Kadomatsu et al., 2011). Angptl2 is also known to induce chronic inflammation (Tazume et al., 2012). 
Angptls do not bind to the Tie2 receptor, but it has recently been reported that the LILRB2 and PIRB are 
receptors for several Angptl family members (Zheng et al., 2012; Oike et al., 2004). Angptl2 is expressed 
in a variety of cells including monocytes, macrophages and in tumors (Okada et al., 2010; Aoi et al., 2011; 
Tazume et al., 2012). Angptl2 has been reported to have a myriad of functions that are involved in 
inflammation, metabolism, angiogenesis and cancer (Kanda et al., 2012; Tazume et al., 2012; Tabata et 
al., 2009). The data obtained in this study demonstrate that PHD3 affects the expression of Angptl2 both 
at protein and RNA levels (Figure 3.19-3.21). The results showed enhanced Angptl2 levels upon 
starvation but decreased Angptl2 expression in the PHD3
-/-
 macrophages. Not only with starvation but also 
other stress inducers such as the NO donor SNAP and the ER stress inducer staurosporine induce the 
expression of Angptl2. In contrast to that, the treatment of BMDMs with SNAP and staurosporine results in 
decreased expression of Angptl2 in PHD3 deficient BMDMs which earlier proved to have decreased 




significantly less secretion of 
Angptl2 into the culture supernatant (Fig. 30). 
 
Above results suggest that differential expression and 
secretion of Angptl2 might play a role in influencing the apoptotic phenotype of the PHD3
-/-
 BMDMs.  
4.6 Loss of Angptl2 attenuates BMDM apoptosis 
 
To analyze the functional role of the decreased expression of Angptl2 in PHD3
-/-
 BMDM and the anti-
apoptotic phenotype, our collaborator partner Prof. Yuichi Oike at Keio University, Japan investigated 
apoptosis in Angptl2
-/- 
BMDM. Previously, it has been reported that in
 




expression of pro-inflammatory cytokines and MMP-9 by activating an NFκB dependent cascade in 
infiltrating macrophages, which accelerates chronic inflammation and promotes destructive remodeling in 
the vessel wall (Tazume et al., 2012). In this study the apoptosis of macrophage was not studied. In 
zebrafish however, Angptl2 knockdown showed minor vascular defects in embryos and also played a 
critical anti-apoptotic role in endothelial cells (Kubota et al., 2005) 
The impact of Angptl2 on macrophages during serum starvation was proven using the Angptl2
-/-
 BMDM. 
These data demonstrated that Angptl2
-/-
 BMDM showed decreased apoptosis compared to wt BMDM 
under serum-induced starvation (Fig. 31). Even upon treatment with other apoptotic stimuli such as SNAP 
and stauro Angptl2
-/-
 BMDM were significantly protected against apoptosis. The above results support the 
conclusion that the altered Angptl2 expression in PHD3
-/-
 BMDM is functionally involved in the apoptosis 
phenotype. Along this line, the decreased Angptl2 expression in PHD3
-/-
 macrophages under serum 
starvation mirrors the shut-down of a death-supporting factor. 
 
4.7 Angptl2 affects macrophage apoptosis 
 
To confirm whether the loss of an autocrine effect of Angptl2 alters the apoptotic phenotype of BMDM, I 
evaluated the effect of adding exogenous Angptl2 to the culture medium. Addition of recombinant Angptl2 
reverses the cell protection phenotype and results in increase apoptosis of PHD3
-/- 
BMDM (Fig. 32). 
Taking into account the high induction of Angptl2 after serum starvation in wt BMDM, this can be 
interpreted as an activation of a protective feedback mechanism. Angptl2 treatment resulted in increased 
apoptosis of PHD3
-/- 
BMDM (Fig. 32), suggesting that Angptl2 regulates BMDM apoptosis in an autocrine 
manner. Angptl2 treatment under serum starvation resulted in an anti-apoptotic effect in the wt BMDM. 
The anti-apoptotic function of Angptl2 is in line with previous reports in endothelial cells (Kubota et al., 
2005). Most interestingly, in PHD3
-/-
 BMDM the response was reverted to a pro-apoptotic effect. Angptl2 
treatment increased the serum-starvation induced cell death of PHD3
-/-
 macrophages but did not affect cell 
viability under normal cell-culture conditions. This implies that Angptl2 is not per se a pro-apoptotic factor 




 It has been previously reported, that Angptl2 signals through integrin α5β1 and PIRB receptors (Okada et 
al., 2010) and that the α5β1 and PIRB are receptors for several Angptl family members (Zheng et al., 
2012; Oike et al., 2004). Analysis of receptors expression showed no difference in the expression level of 





























5. Conclusion and Outlook 
 
 
In the present thesis, results showed for the first time a functional connection between PHD3 and Angptl2. 
In this study myeloid-specific PHD3-deficient macrophages were investigated. The PHD3
-/-
 BMDM did not 
show an altered expression of the two other HIF-regulating PHDs, i.e. PHD1 and PHD2. Also the knockout 
BMDM showed no altered/increased HIF-1α or HIF-2α protein levels in normoxia and hypoxia. Further, the 
results were substantiated by the fact that the HIF target gene expression was unaltered in the PHD3
-/-
 
BMDM compared to wt cells. Macrophage M1 and M2-polarization remained unaltered as well. PHD3 has 
been associated with apoptotic cell death mechanisms in various cell types. In this study, macrophages 
were investigated regarding differences in apoptosis using TUNEL and Annexin V staining. TUNEL 
staining revealed under starvation a decrease in number of apoptotic PHD3
-/- 
macrophages as compared 
to wt. The same results were confirmed using the early apoptotic marker Annexin V. Treatment with 
apoptotic inducers such as SNAP and staurosporine confirmed that PHD3
-/- 
macrophages are less 
apoptotic. In line calcein uptake results revealed that PHD3
-/-
 cells are significantly more viable compared 
to wt BMDM. When the supernatant medium from the cultured macrophages was exchanged between the 
genotypes after 24 hrs of culture, PHD3
-/-
 macrophages showed more Annexin V staining indicating that at 
least in part a secreted factor is involved in the PHD3
-/-
 apoptosis mechanism. In an unbiased 
transcriptome screen comparing starved wt and PHD3
-/-
 BMDM, I found a significant difference in the 
starvation-induced Angptl2 RNA. These data demonstrate that PHD3 affects the production of Angptl2 
and additionally influences the response towards this apoptosis modulating factor. Further, treatment with 
recombinant Angptl2 rescued the anti-apoptotic phenotype demonstrating that it is involved in the PHD3-
mediated response towards apoptotic stimuli in macrophages. My data was further strengthened by 
investigating apoptosis in Angptl2
-/-
 BMDM, which showed decreased apoptosis compared to wt BMDM 
supporting the lower expression of Angptl2 in PHD3
-/-
 BMDM followed by decreased apoptosis. Taken 
together, my data demonstrate for the first time that PHD3 plays a critical role for cell survival decisions in 
macrophages. This includes apoptotic cell death induced by serum starvation, which mimics in part 
ischemic conditions but also treatment with stauro or the endogenous inducers of apoptosis like the NO 
donor SNAP or LPS. The anti-apoptotic effect in the PHD3
-/- 
BMDM is at least partially mediated by an 




altered production and response to Angptl2. Findings such that inhibition of PHD3 can boost the innate 
immune defense might be exploited for clinical treatment strategies. Further research on loss of PHD3 and 
its effect on myeloid cell apoptosis is important to be investigated in more detail to determine the outcome 
on damaged tissue repair and tissue remodeling. Since macrophages are responsible for the early 
immune response, the data imply that PHD3 may shape this response by altering the life expectancies of 
macrophages in inflamed and ischemic tissues. Regardless of underlying molecular mechanisms, the 
present findings, that loss of PHD3 results in an increased lifespan of macrophages might have 
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